CA2371597A1 - Methods and gene products for altering the shape of cells and organs in plants - Google Patents
Methods and gene products for altering the shape of cells and organs in plants Download PDFInfo
- Publication number
- CA2371597A1 CA2371597A1 CA002371597A CA2371597A CA2371597A1 CA 2371597 A1 CA2371597 A1 CA 2371597A1 CA 002371597 A CA002371597 A CA 002371597A CA 2371597 A CA2371597 A CA 2371597A CA 2371597 A1 CA2371597 A1 CA 2371597A1
- Authority
- CA
- Canada
- Prior art keywords
- geg
- cell
- expression
- corolla
- plant
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 108090000623 proteins and genes Proteins 0.000 title claims abstract description 79
- 210000000056 organ Anatomy 0.000 title claims abstract description 37
- 238000000034 method Methods 0.000 title description 17
- 230000010261 cell growth Effects 0.000 claims abstract description 49
- 210000004027 cell Anatomy 0.000 claims description 98
- 241000196324 Embryophyta Species 0.000 claims description 92
- 150000007523 nucleic acids Chemical group 0.000 claims description 31
- 239000002299 complementary DNA Substances 0.000 claims description 28
- 241000791020 Gerbera hybrid cultivar Species 0.000 claims description 9
- 108091028043 Nucleic acid sequence Proteins 0.000 claims description 8
- 210000004899 c-terminal region Anatomy 0.000 claims description 8
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 5
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 5
- 229920001184 polypeptide Polymers 0.000 claims description 4
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 claims description 3
- 125000000151 cysteine group Chemical group N[C@@H](CS)C(=O)* 0.000 claims description 3
- 125000003275 alpha amino acid group Chemical group 0.000 claims 2
- 238000004519 manufacturing process Methods 0.000 abstract description 12
- 230000012010 growth Effects 0.000 abstract description 11
- 238000003898 horticulture Methods 0.000 abstract description 9
- 239000002994 raw material Substances 0.000 abstract description 4
- 241001573881 Corolla Species 0.000 description 108
- 230000014509 gene expression Effects 0.000 description 93
- 238000004458 analytical method Methods 0.000 description 30
- 210000001339 epidermal cell Anatomy 0.000 description 24
- IXORZMNAPKEEDV-OBDJNFEBSA-N gibberellin A3 Chemical compound C([C@@]1(O)C(=C)C[C@@]2(C1)[C@H]1C(O)=O)C[C@H]2[C@]2(C=C[C@@H]3O)[C@H]1[C@]3(C)C(=O)O2 IXORZMNAPKEEDV-OBDJNFEBSA-N 0.000 description 21
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 20
- IXORZMNAPKEEDV-UHFFFAOYSA-N gibberellic acid GA3 Natural products OC(=O)C1C2(C3)CC(=C)C3(O)CCC2C2(C=CC3O)C1C3(C)C(=O)O2 IXORZMNAPKEEDV-UHFFFAOYSA-N 0.000 description 19
- 239000005980 Gibberellic acid Substances 0.000 description 18
- 238000011161 development Methods 0.000 description 17
- 230000018109 developmental process Effects 0.000 description 17
- 230000009261 transgenic effect Effects 0.000 description 16
- 239000000499 gel Substances 0.000 description 15
- 150000001413 amino acids Chemical group 0.000 description 11
- 230000001276 controlling effect Effects 0.000 description 11
- 241000735332 Gerbera Species 0.000 description 10
- 230000001105 regulatory effect Effects 0.000 description 10
- 235000007688 Lycopersicon esculentum Nutrition 0.000 description 9
- 240000003768 Solanum lycopersicum Species 0.000 description 9
- 238000009396 hybridization Methods 0.000 description 9
- 108020004707 nucleic acids Proteins 0.000 description 9
- 102000039446 nucleic acids Human genes 0.000 description 9
- 239000012634 fragment Substances 0.000 description 8
- 235000018102 proteins Nutrition 0.000 description 8
- 102000004169 proteins and genes Human genes 0.000 description 8
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 7
- 108020004414 DNA Proteins 0.000 description 7
- 229930195732 phytohormone Natural products 0.000 description 7
- 241000219194 Arabidopsis Species 0.000 description 6
- 230000000694 effects Effects 0.000 description 6
- 239000000523 sample Substances 0.000 description 6
- 210000001519 tissue Anatomy 0.000 description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 5
- 108010076504 Protein Sorting Signals Proteins 0.000 description 5
- 235000001014 amino acid Nutrition 0.000 description 5
- 230000000692 anti-sense effect Effects 0.000 description 5
- 238000007901 in situ hybridization Methods 0.000 description 5
- 238000005259 measurement Methods 0.000 description 5
- 230000001404 mediated effect Effects 0.000 description 5
- 108020004999 messenger RNA Proteins 0.000 description 5
- 238000012353 t test Methods 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- 241000207748 Petunia Species 0.000 description 4
- 101100419802 Solanum lycopersicum RSI-1 gene Proteins 0.000 description 4
- 229930006000 Sucrose Natural products 0.000 description 4
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 4
- 210000002421 cell wall Anatomy 0.000 description 4
- 230000007423 decrease Effects 0.000 description 4
- 210000002615 epidermis Anatomy 0.000 description 4
- 230000002401 inhibitory effect Effects 0.000 description 4
- 238000004626 scanning electron microscopy Methods 0.000 description 4
- 238000012216 screening Methods 0.000 description 4
- 239000005720 sucrose Substances 0.000 description 4
- 230000009466 transformation Effects 0.000 description 4
- 239000013598 vector Substances 0.000 description 4
- 229930192334 Auxin Natural products 0.000 description 3
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 3
- KSFQPRLZAUXXPT-GARJFASQSA-N Lys-Cys-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CS)NC(=O)[C@H](CCCCN)N)C(=O)O KSFQPRLZAUXXPT-GARJFASQSA-N 0.000 description 3
- 239000002363 auxin Substances 0.000 description 3
- 230000033228 biological regulation Effects 0.000 description 3
- 230000003247 decreasing effect Effects 0.000 description 3
- 239000000835 fiber Substances 0.000 description 3
- 230000008124 floral development Effects 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- SEOVTRFCIGRIMH-UHFFFAOYSA-N indole-3-acetic acid Chemical compound C1=CC=C2C(CC(=O)O)=CNC2=C1 SEOVTRFCIGRIMH-UHFFFAOYSA-N 0.000 description 3
- 230000006698 induction Effects 0.000 description 3
- 230000005305 organ development Effects 0.000 description 3
- 230000008635 plant growth Effects 0.000 description 3
- 238000001878 scanning electron micrograph Methods 0.000 description 3
- 230000008685 targeting Effects 0.000 description 3
- 230000002123 temporal effect Effects 0.000 description 3
- 238000013518 transcription Methods 0.000 description 3
- 230000035897 transcription Effects 0.000 description 3
- 108020005029 5' Flanking Region Proteins 0.000 description 2
- 229920001817 Agar Polymers 0.000 description 2
- 241000589155 Agrobacterium tumefaciens Species 0.000 description 2
- WRDANSJTFOHBPI-FXQIFTODSA-N Ala-Arg-Cys Chemical compound C[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CS)C(=O)O)N WRDANSJTFOHBPI-FXQIFTODSA-N 0.000 description 2
- 241000208838 Asteraceae Species 0.000 description 2
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 2
- 108020005120 Plant DNA Proteins 0.000 description 2
- 108020004518 RNA Probes Proteins 0.000 description 2
- 239000003391 RNA probe Substances 0.000 description 2
- 101100067747 Solanum lycopersicum GAST1 gene Proteins 0.000 description 2
- 239000008272 agar Substances 0.000 description 2
- 230000019552 anatomical structure morphogenesis Effects 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 238000010805 cDNA synthesis kit Methods 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 238000003776 cleavage reaction Methods 0.000 description 2
- 230000002596 correlated effect Effects 0.000 description 2
- 235000018417 cysteine Nutrition 0.000 description 2
- ZMMJGEGLRURXTF-UHFFFAOYSA-N ethidium bromide Chemical compound [Br-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CC)=C1C1=CC=CC=C1 ZMMJGEGLRURXTF-UHFFFAOYSA-N 0.000 description 2
- 229960005542 ethidium bromide Drugs 0.000 description 2
- 239000005556 hormone Substances 0.000 description 2
- 229940088597 hormone Drugs 0.000 description 2
- 238000002955 isolation Methods 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 230000035772 mutation Effects 0.000 description 2
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 2
- 230000002797 proteolythic effect Effects 0.000 description 2
- 230000014493 regulation of gene expression Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 230000007017 scission Effects 0.000 description 2
- 230000019491 signal transduction Effects 0.000 description 2
- 238000010186 staining Methods 0.000 description 2
- ZTLXICJMNFREPA-UHFFFAOYSA-N 3,3,6,6,9,9-hexamethyl-1,2,4,5,7,8-hexaoxonane Chemical compound CC1(C)OOC(C)(C)OOC(C)(C)OO1 ZTLXICJMNFREPA-UHFFFAOYSA-N 0.000 description 1
- UWQJHXKARZWDIJ-ZLUOBGJFSA-N Ala-Ala-Cys Chemical compound C[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](CS)C(O)=O UWQJHXKARZWDIJ-ZLUOBGJFSA-N 0.000 description 1
- 108010011667 Ala-Phe-Ala Proteins 0.000 description 1
- 239000004382 Amylase Substances 0.000 description 1
- HJVGMOYJDDXLMI-AVGNSLFASA-N Arg-Arg-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](N)CCCNC(N)=N HJVGMOYJDDXLMI-AVGNSLFASA-N 0.000 description 1
- RWDVGVPHEWOZMO-GUBZILKMSA-N Arg-Cys-Val Chemical compound CC(C)[C@H](NC(=O)[C@H](CS)NC(=O)[C@@H](N)CCCNC(N)=N)C(O)=O RWDVGVPHEWOZMO-GUBZILKMSA-N 0.000 description 1
- VENMDXUVHSKEIN-GUBZILKMSA-N Arg-Ser-Arg Chemical compound NC(N)=NCCC[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCN=C(N)N)C(O)=O VENMDXUVHSKEIN-GUBZILKMSA-N 0.000 description 1
- RRVBEKYEFMCDIF-WHFBIAKZSA-N Asn-Cys-Gly Chemical compound C([C@@H](C(=O)N[C@@H](CS)C(=O)NCC(=O)O)N)C(=O)N RRVBEKYEFMCDIF-WHFBIAKZSA-N 0.000 description 1
- QNJIRRVTOXNGMH-GUBZILKMSA-N Asn-Gln-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)CC(N)=O QNJIRRVTOXNGMH-GUBZILKMSA-N 0.000 description 1
- MPXTVIOEYISUQC-DHATWTDPSA-N Asn-Met-Thr-Thr Chemical compound CSCC[C@H](NC(=O)[C@@H](N)CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O MPXTVIOEYISUQC-DHATWTDPSA-N 0.000 description 1
- 125000001433 C-terminal amino-acid group Chemical group 0.000 description 1
- 101100008049 Caenorhabditis elegans cut-5 gene Proteins 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 241000701489 Cauliflower mosaic virus Species 0.000 description 1
- MBPKYKSYUAPLMY-DCAQKATOSA-N Cys-Arg-Leu Chemical compound [H]N[C@@H](CS)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(O)=O MBPKYKSYUAPLMY-DCAQKATOSA-N 0.000 description 1
- LDIKUWLAMDFHPU-FXQIFTODSA-N Cys-Cys-Arg Chemical compound [H]N[C@@H](CS)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O LDIKUWLAMDFHPU-FXQIFTODSA-N 0.000 description 1
- UFOBYROTHHYVGW-CIUDSAMLSA-N Cys-Cys-His Chemical compound [H]N[C@@H](CS)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC1=CNC=N1)C(O)=O UFOBYROTHHYVGW-CIUDSAMLSA-N 0.000 description 1
- OXOQBEVULIBOSH-ZDLURKLDSA-N Cys-Gly-Thr Chemical compound [H]N[C@@H](CS)C(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(O)=O OXOQBEVULIBOSH-ZDLURKLDSA-N 0.000 description 1
- ANPADMNVVOOYKW-DCAQKATOSA-N Cys-His-Arg Chemical compound [H]N[C@@H](CS)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O ANPADMNVVOOYKW-DCAQKATOSA-N 0.000 description 1
- WXOFKRKAHJQKLT-BQBZGAKWSA-N Cys-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@@H](N)CS WXOFKRKAHJQKLT-BQBZGAKWSA-N 0.000 description 1
- ZKAUCGZIIXXWJQ-BZSNNMDCSA-N Cys-Tyr-Tyr Chemical compound C1=CC(=CC=C1C[C@@H](C(=O)N[C@@H](CC2=CC=C(C=C2)O)C(=O)O)NC(=O)[C@H](CS)N)O ZKAUCGZIIXXWJQ-BZSNNMDCSA-N 0.000 description 1
- 101100456896 Drosophila melanogaster metl gene Proteins 0.000 description 1
- 229930191978 Gibberellin Natural products 0.000 description 1
- FYBSCGZLICNOBA-XQXXSGGOSA-N Glu-Ala-Thr Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O FYBSCGZLICNOBA-XQXXSGGOSA-N 0.000 description 1
- UPOJUWHGMDJUQZ-IUCAKERBSA-N Gly-Arg-Arg Chemical compound NC(=N)NCCC[C@H](NC(=O)CN)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O UPOJUWHGMDJUQZ-IUCAKERBSA-N 0.000 description 1
- WJZLEENECIOOSA-WDSKDSINSA-N Gly-Asn-Gln Chemical compound NCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)O WJZLEENECIOOSA-WDSKDSINSA-N 0.000 description 1
- 102100040870 Glycine amidinotransferase, mitochondrial Human genes 0.000 description 1
- FDQYIRHBVVUTJF-ZETCQYMHSA-N His-Gly-Gly Chemical compound [O-]C(=O)CNC(=O)CNC(=O)[C@@H]([NH3+])CC1=CN=CN1 FDQYIRHBVVUTJF-ZETCQYMHSA-N 0.000 description 1
- 101000893303 Homo sapiens Glycine amidinotransferase, mitochondrial Proteins 0.000 description 1
- 240000005979 Hordeum vulgare Species 0.000 description 1
- 235000007340 Hordeum vulgare Nutrition 0.000 description 1
- NKVZTQVGUNLLQW-JBDRJPRFSA-N Ile-Ala-Ala Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)O)N NKVZTQVGUNLLQW-JBDRJPRFSA-N 0.000 description 1
- VSZALHITQINTGC-GHCJXIJMSA-N Ile-Ala-Asp Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)O)N VSZALHITQINTGC-GHCJXIJMSA-N 0.000 description 1
- VGSPNSSCMOHRRR-BJDJZHNGSA-N Ile-Ser-Lys Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)O)N VGSPNSSCMOHRRR-BJDJZHNGSA-N 0.000 description 1
- 108010065920 Insulin Lispro Proteins 0.000 description 1
- LJKJVTCIRDCITR-SRVKXCTJSA-N Leu-Cys-His Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)N LJKJVTCIRDCITR-SRVKXCTJSA-N 0.000 description 1
- FIYMBBHGYNQFOP-IUCAKERBSA-N Leu-Gly-Gln Chemical compound CC(C)C[C@@H](C(=O)NCC(=O)N[C@@H](CCC(=O)N)C(=O)O)N FIYMBBHGYNQFOP-IUCAKERBSA-N 0.000 description 1
- IDGZVZJLYFTXSL-DCAQKATOSA-N Leu-Ser-Arg Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@H](C(O)=O)CCCN=C(N)N IDGZVZJLYFTXSL-DCAQKATOSA-N 0.000 description 1
- GOFJOGXGMPHOGL-DCAQKATOSA-N Leu-Ser-Met Chemical compound CSCC[C@@H](C(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC(C)C GOFJOGXGMPHOGL-DCAQKATOSA-N 0.000 description 1
- RVOMPSJXSRPFJT-DCAQKATOSA-N Lys-Ala-Arg Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O RVOMPSJXSRPFJT-DCAQKATOSA-N 0.000 description 1
- OZVXDDFYCQOPFD-XQQFMLRXSA-N Lys-Val-Pro Chemical compound CC(C)[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](CCCCN)N OZVXDDFYCQOPFD-XQQFMLRXSA-N 0.000 description 1
- 108091092724 Noncoding DNA Proteins 0.000 description 1
- 238000000636 Northern blotting Methods 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 238000012408 PCR amplification Methods 0.000 description 1
- BBDSZDHUCPSYAC-QEJZJMRPSA-N Phe-Ala-Leu Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(O)=O BBDSZDHUCPSYAC-QEJZJMRPSA-N 0.000 description 1
- 108700001094 Plant Genes Proteins 0.000 description 1
- AMBLXEMWFARNNQ-DCAQKATOSA-N Pro-Asn-Leu Chemical compound CC(C)C[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)N)NC(=O)[C@@H]1CCCN1 AMBLXEMWFARNNQ-DCAQKATOSA-N 0.000 description 1
- ZUZINZIJHJFJRN-UBHSHLNASA-N Pro-Phe-Ala Chemical compound C([C@@H](C(=O)N[C@@H](C)C(O)=O)NC(=O)[C@H]1NCCC1)C1=CC=CC=C1 ZUZINZIJHJFJRN-UBHSHLNASA-N 0.000 description 1
- LEIKGVHQTKHOLM-IUCAKERBSA-N Pro-Pro-Gly Chemical compound OC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H]1NCCC1 LEIKGVHQTKHOLM-IUCAKERBSA-N 0.000 description 1
- 108010029485 Protein Isoforms Proteins 0.000 description 1
- 102000001708 Protein Isoforms Human genes 0.000 description 1
- 101710105986 Putative cell wall protein Proteins 0.000 description 1
- 108091034057 RNA (poly(A)) Proteins 0.000 description 1
- 238000002123 RNA extraction Methods 0.000 description 1
- 108020004511 Recombinant DNA Proteins 0.000 description 1
- BKOKTRCZXRIQPX-ZLUOBGJFSA-N Ser-Ala-Cys Chemical compound C[C@@H](C(=O)N[C@@H](CS)C(=O)O)NC(=O)[C@H](CO)N BKOKTRCZXRIQPX-ZLUOBGJFSA-N 0.000 description 1
- LRWBCWGEUCKDTN-BJDJZHNGSA-N Ser-Lys-Ile Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O LRWBCWGEUCKDTN-BJDJZHNGSA-N 0.000 description 1
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 1
- DGOJNGCGEYOBKN-BWBBJGPYSA-N Thr-Cys-Cys Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CS)C(=O)O)N)O DGOJNGCGEYOBKN-BWBBJGPYSA-N 0.000 description 1
- SGAOHNPSEPVAFP-ZDLURKLDSA-N Thr-Ser-Gly Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(=O)NCC(O)=O SGAOHNPSEPVAFP-ZDLURKLDSA-N 0.000 description 1
- FMOSEWZYZPMJAL-KKUMJFAQSA-N Tyr-Glu-Met Chemical compound CSCC[C@@H](C(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC1=CC=C(C=C1)O)N FMOSEWZYZPMJAL-KKUMJFAQSA-N 0.000 description 1
- GZWPQZDVTBZVEP-BZSNNMDCSA-N Tyr-Tyr-Asn Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC(N)=O)C(O)=O GZWPQZDVTBZVEP-BZSNNMDCSA-N 0.000 description 1
- OGNMURQZFMHFFD-NHCYSSNCSA-N Val-Asn-Lys Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CCCCN)C(=O)O)N OGNMURQZFMHFFD-NHCYSSNCSA-N 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 238000001042 affinity chromatography Methods 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 239000004411 aluminium Substances 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- 239000004410 anthocyanin Substances 0.000 description 1
- 229930002877 anthocyanin Natural products 0.000 description 1
- 235000010208 anthocyanin Nutrition 0.000 description 1
- 150000004636 anthocyanins Chemical class 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 108010068380 arginylarginine Proteins 0.000 description 1
- 108010060035 arginylproline Proteins 0.000 description 1
- 108010038633 aspartylglutamate Proteins 0.000 description 1
- 238000000376 autoradiography Methods 0.000 description 1
- 230000008194 carpel development Effects 0.000 description 1
- 230000032823 cell division Effects 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 230000000875 corresponding effect Effects 0.000 description 1
- 244000038559 crop plants Species 0.000 description 1
- 108010060199 cysteinylproline Proteins 0.000 description 1
- 230000026959 developmental induction Effects 0.000 description 1
- 230000009025 developmental regulation Effects 0.000 description 1
- 238000010218 electron microscopic analysis Methods 0.000 description 1
- 238000001493 electron microscopy Methods 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 239000003623 enhancer Substances 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- 238000010195 expression analysis Methods 0.000 description 1
- 210000001723 extracellular space Anatomy 0.000 description 1
- 230000004927 fusion Effects 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 230000004034 genetic regulation Effects 0.000 description 1
- 239000003448 gibberellin Substances 0.000 description 1
- VPZXBVLAVMBEQI-UHFFFAOYSA-N glycyl-DL-alpha-alanine Natural products OC(=O)C(C)NC(=O)CN VPZXBVLAVMBEQI-UHFFFAOYSA-N 0.000 description 1
- 229910002804 graphite Inorganic materials 0.000 description 1
- 239000010439 graphite Substances 0.000 description 1
- 108010036413 histidylglycine Proteins 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 238000010249 in-situ analysis Methods 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 230000011890 leaf development Effects 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 238000001000 micrograph Methods 0.000 description 1
- 230000000394 mitotic effect Effects 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 238000010369 molecular cloning Methods 0.000 description 1
- 239000002773 nucleotide Substances 0.000 description 1
- 125000003729 nucleotide group Chemical group 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- 229910052763 palladium Inorganic materials 0.000 description 1
- 238000005192 partition Methods 0.000 description 1
- 230000000243 photosynthetic effect Effects 0.000 description 1
- 230000019612 pigmentation Effects 0.000 description 1
- 238000003976 plant breeding Methods 0.000 description 1
- 230000008121 plant development Effects 0.000 description 1
- 229910052697 platinum Inorganic materials 0.000 description 1
- 230000002028 premature Effects 0.000 description 1
- 108010087846 prolyl-prolyl-glycine Proteins 0.000 description 1
- 108010079317 prolyl-tyrosine Proteins 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000034515 regulation of cell shape Effects 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 230000021749 root development Effects 0.000 description 1
- 230000009758 senescence Effects 0.000 description 1
- 238000007493 shaping process Methods 0.000 description 1
- 238000004904 shortening Methods 0.000 description 1
- 229910052709 silver Inorganic materials 0.000 description 1
- 239000004332 silver Substances 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 238000012731 temporal analysis Methods 0.000 description 1
- 108010061238 threonyl-glycine Proteins 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 108010015385 valyl-prolyl-proline Proteins 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
- C12N15/8261—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8216—Methods for controlling, regulating or enhancing expression of transgenes in plant cells
- C12N15/8222—Developmentally regulated expression systems, tissue, organ specific, temporal or spatial regulation
- C12N15/823—Reproductive tissue-specific promoters
- C12N15/8233—Female-specific, e.g. pistil, ovule
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8216—Methods for controlling, regulating or enhancing expression of transgenes in plant cells
- C12N15/8237—Externally regulated expression systems
- C12N15/8238—Externally regulated expression systems chemically inducible, e.g. tetracycline
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A40/00—Adaptation technologies in agriculture, forestry, livestock or agroalimentary production
- Y02A40/10—Adaptation technologies in agriculture, forestry, livestock or agroalimentary production in agriculture
- Y02A40/146—Genetically Modified [GMO] plants, e.g. transgenic plants
Landscapes
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Organic Chemistry (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Botany (AREA)
- Pregnancy & Childbirth (AREA)
- Reproductive Health (AREA)
- General Chemical & Material Sciences (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
Abstract
The present invention is related to GEG-like genes and their gene products capable of controlling the direction and dimensions of cell growth. These genes and gene products can be applied for altering the size shape of plant cells and/or organs. An expansion in either radial growth or longitudinal growth of the plant cell is desirable. Said genes and gene products are useful in agriculture, horticulture and forestry for manufacturing renewable plant-derived raw-material structures more convenient, advantageous and applicable in the respective application.
Description
Methods and Gene Products for Altering the Shape of Cells and Organs in Plants The Technical Field of the Invention The present invention is related to a method for adjusting the shape of plant cells and plant organs. The invention is also related to GEG cDNA or GEG-like nucleic acid sequences and their products useful in horticulture, agriculture and forestry for manufac-turing renewable plant-derived raw-materials with structures more convenient, advanta-genus and feasible for the respective application.
The Background of the Invention The highly invariable shape and size of floral organs, suggests that their shape is under strict developmental control. During flower development, the final shape of the floral organs typically occurs after mitotic activity has basically ceased, indicating that cell expansion plays an important role in determining organ shape (Pyke, K. A. , et al. , J.
Exp. Bot. 42, 1407-1416, 1991; Tsuge, T., et al., Development 122, 1589-1600, 1996).
Mutations for leaf development (Tsuge, T,. et al., Development 122, 1589-1600, 1996) and several cell expansion mutations for root development in Arabidopsis (Aeschbacher, R. A., et al., Genes & Development 9, 330-340, 1991; Hauser, M.-T., et al., Development 121, 1237-1252, 1995) point to an interrelationship between the longitudinal and radial dimensions of the cell. Mutants have been shown to exhibit restricted expansion in leaf-width direction and enhanced expansion in leaf thickness. In some plants morphology is affected in one direction only and in others in several directions .
Because plants are one of the most important renewable resources in nature, it would be beneficial to be able to control the direction and dimension of cell growth and organ shape in plants. The capability of controlling and regulating the direction and dimension of cell growth could be utilized to provide the most convenient and advantageous shape or structure for any desired application in agriculture, horticulture and forestry. Either increased longitudinal, e.g. longer cells or fibers could be beneficial for some applications in pulp and paper industry, whereas radial cell growth could be desired in many other applications. So far the molecular and genetic regulation of cell expansion is not well understood and especially the molecular control of organ shape during flower de-velopment is still largely unknown.
The Background of the Invention The highly invariable shape and size of floral organs, suggests that their shape is under strict developmental control. During flower development, the final shape of the floral organs typically occurs after mitotic activity has basically ceased, indicating that cell expansion plays an important role in determining organ shape (Pyke, K. A. , et al. , J.
Exp. Bot. 42, 1407-1416, 1991; Tsuge, T., et al., Development 122, 1589-1600, 1996).
Mutations for leaf development (Tsuge, T,. et al., Development 122, 1589-1600, 1996) and several cell expansion mutations for root development in Arabidopsis (Aeschbacher, R. A., et al., Genes & Development 9, 330-340, 1991; Hauser, M.-T., et al., Development 121, 1237-1252, 1995) point to an interrelationship between the longitudinal and radial dimensions of the cell. Mutants have been shown to exhibit restricted expansion in leaf-width direction and enhanced expansion in leaf thickness. In some plants morphology is affected in one direction only and in others in several directions .
Because plants are one of the most important renewable resources in nature, it would be beneficial to be able to control the direction and dimension of cell growth and organ shape in plants. The capability of controlling and regulating the direction and dimension of cell growth could be utilized to provide the most convenient and advantageous shape or structure for any desired application in agriculture, horticulture and forestry. Either increased longitudinal, e.g. longer cells or fibers could be beneficial for some applications in pulp and paper industry, whereas radial cell growth could be desired in many other applications. So far the molecular and genetic regulation of cell expansion is not well understood and especially the molecular control of organ shape during flower de-velopment is still largely unknown.
The objectives of the present invention is to provide new methods for altering or adjusting the shape of plant cells and organs by controlling andlor regulating the direction, both in longitudinal and radial direction, as well as the magnitude of cell growth.
Another objective of the present invention is to provide means carrying out said method.
The means are GEG cDNA or GEG-like nucleic acid sequences, including promoters of said GEG or GEG-like genes or nucleic acid sequences capable of directing foreign genes or heterologous nucleic acid sequences in desired direction. The GEG-like gene products of said nucleic acid sequences are useful in agriculture, horticulture and forestry for manufacturing renewable plant-derived raw-materials with structures more conve-nient, advantageous and feasible for the respective application.
Especially preferred objectives of the present invention in forestry is to enable modification of the length and/or breadth of the fibers obtainable for example from wood. In agriculture or horticulture one of the desired objectives is to provide shorter and broader stems which are more stable or resistant to crop flattening by rain, etc.
In horticulture the objective could be to modify the shape of flowers and; or leaves to provide more decorative forms or longer flower bearing stems as well as other desirable properties in the plants in question.
The Summary of the Invention The present inventions provides a solution to said problems by providing new methods for controlling the direction of cell growth and organ shaping in plants. The method and the products and means utilized in said method are as defined in the claims of the present invention.
A Short Description of the Drawings Figure 1. RNA gel blot hybridisation analysis showing the tissue specificity of GEG
expression.
Figure 2. Analysis of GEG expression during corolla and carpet development.
Another objective of the present invention is to provide means carrying out said method.
The means are GEG cDNA or GEG-like nucleic acid sequences, including promoters of said GEG or GEG-like genes or nucleic acid sequences capable of directing foreign genes or heterologous nucleic acid sequences in desired direction. The GEG-like gene products of said nucleic acid sequences are useful in agriculture, horticulture and forestry for manufacturing renewable plant-derived raw-materials with structures more conve-nient, advantageous and feasible for the respective application.
Especially preferred objectives of the present invention in forestry is to enable modification of the length and/or breadth of the fibers obtainable for example from wood. In agriculture or horticulture one of the desired objectives is to provide shorter and broader stems which are more stable or resistant to crop flattening by rain, etc.
In horticulture the objective could be to modify the shape of flowers and; or leaves to provide more decorative forms or longer flower bearing stems as well as other desirable properties in the plants in question.
The Summary of the Invention The present inventions provides a solution to said problems by providing new methods for controlling the direction of cell growth and organ shaping in plants. The method and the products and means utilized in said method are as defined in the claims of the present invention.
A Short Description of the Drawings Figure 1. RNA gel blot hybridisation analysis showing the tissue specificity of GEG
expression.
Figure 2. Analysis of GEG expression during corolla and carpet development.
Figure 3. Analysis of GEG expression in carpet and corolla by in situ hybridization.
Figure 4. Biometric analysis of corolla and carpet length and width development.
Figure 5. Cell length and width in distal and central regions of ray floret corolla just prior and after the opening (stages 7+ and 8, respectively).
Figure 6. Comparison of the ray floret corollas of a non-transformed line (wt) with that of an m3 plant constitutively expressing GEG before (stage 7), during (7.5), and after (9) the opening of ray florets.
Figure 7. Analysis of corolla length and width for four lines constitutively expressing GEG and the corn ~1 lines.
Figure 8. Analysis of the effects of constitutive GEG expression on corolla epidermal cells.
Figure 9. Cell lengths and widths in the same regions as described in Figure 8 of ml and m3 lines constitutively expressing GEG and a control line (wt). In plants constitutively expressing GEG, cell length was reduced but no difference in cell width could be mea-sured.
Figure 10. Scanning electron microscopy of the epidermis of stylar part of the carpet 300 m below the stigma. In an ml line constitutively expressing GEG, cell length was reduced and the width was increased compared to control line.
Figure 11. Analysis of the effects of constitutive GEG expression on epidermal cells of the carpet style.
Figure 12. Exogenous gibberellic acid application upregulates GEG expression in ray floret corollas Figure 13. The promoter sequence, the cDNA sequence and the amino acid sequence of the GEG-gene product are shown as well as the points of initiation and termination of the sequences pertinent in the present invention.
Figure 4. Biometric analysis of corolla and carpet length and width development.
Figure 5. Cell length and width in distal and central regions of ray floret corolla just prior and after the opening (stages 7+ and 8, respectively).
Figure 6. Comparison of the ray floret corollas of a non-transformed line (wt) with that of an m3 plant constitutively expressing GEG before (stage 7), during (7.5), and after (9) the opening of ray florets.
Figure 7. Analysis of corolla length and width for four lines constitutively expressing GEG and the corn ~1 lines.
Figure 8. Analysis of the effects of constitutive GEG expression on corolla epidermal cells.
Figure 9. Cell lengths and widths in the same regions as described in Figure 8 of ml and m3 lines constitutively expressing GEG and a control line (wt). In plants constitutively expressing GEG, cell length was reduced but no difference in cell width could be mea-sured.
Figure 10. Scanning electron microscopy of the epidermis of stylar part of the carpet 300 m below the stigma. In an ml line constitutively expressing GEG, cell length was reduced and the width was increased compared to control line.
Figure 11. Analysis of the effects of constitutive GEG expression on epidermal cells of the carpet style.
Figure 12. Exogenous gibberellic acid application upregulates GEG expression in ray floret corollas Figure 13. The promoter sequence, the cDNA sequence and the amino acid sequence of the GEG-gene product are shown as well as the points of initiation and termination of the sequences pertinent in the present invention.
The Detailed Description of the Invention Definitions In the present invention the terms used have the meaning they generally have in the fields of conventional plant breeding, plant biochemistry and production of transgenic plants, including recombinant DNA technology as well as agriculture, horticulture and forestry. Some terms, however, are used with a somewhat deviating or broader meaning in this context. Accordingly, in order to avoid uncertainty caused by terms with unclear meaning some of the terms used in this specification and in the claims are defined in more detail below.
The term "GEG" for "~erbera GASTI-like gene" means an isolated and essentially purified cDNA sequence (Gerbera hybrida homolog for the gibberellic acid stimulated transcript 1 [GASTI], from tomato) obtainable from a library representing late stages of corolla development in Gerbera hybrida.
The term "GEG-like nucleic acid sequences" means nucleic acid sequences homologous to said GEG-gene or cDNA. The "GEG-like nucleic acid sequences" are characterized by a nucleic acid sequence encoding "GEG-like gene products" having an amino acid sequence substantially homologous with the C-terminal domain (SEQ ID NO:1: ) of the gene product of GEG (SEQ ID N0:2:). Said °'GEG-like nucleic acid sequences" are further substantially similar at nucleotide level with the GEG cDNA (SEQ ID
N0:3:). In its broadest aspect GEG-like nucleic acid sequences include the GEG-promoter SEQ ID
N0:4: as well as substantially homologous promoters, which are capable of directing a foreign gene or a heterologous nucleic acid sequence in the same way as GEG is directed by its native promoter in corolla and styles.
Said "GEG-like nucleic acid sequences" are further characterized by the capacity of spatiotemporal controlling of the plant cell growth by alternatively increasing and/or decreasing the cell growth in various directions or by directing said function.
Typical examples of such GEG-like nucleic acid sequences include isolated, essentially purified nucleotide sequences obtainable, for example, by differential hybridization from a group of plant genes having a high similarity with the GEG cDNA from Gerbera hybrida.
The term "DNA construct for altering the size and shape of plant cells or plant organs"
means any suitable vectors and/or DNA constructs comprising at least one GEG-like nucleic acid sequences combined with optional promoters, enhancers, signal sequences for inserting, targetting, controlling the size and shape of plants cells and plant organs.
The term "GEG gene product" means an amino acid sequence with the deduced amino acid sequence (SEQ ID N0:2:) sharing a high similarity with previously characterized putative cell wall proteins encoded by GEG-like nucleic acid sequences. The "GEG-like gene products" are polypeptides characterized by having an amino acid sequence comprising amino acid sequences substantially homologous with SEQ ID N0:2:, which are further characterized by having a highly conserved C-terminal domain, with one or more invariable cysteine residues. The "GEG-like gene products" are further characterized by the capacity of spatiotemporal control of cell growth, which can be determined by methods disclosed in the examples.
The term "GEG-like gene products" include in addition to said GEG-gene product, products obtainable by constitutive or induced expression of gibberellic acid-inducible genes, namely GAST1 of tomato, GIP (for gibberellin-induced gene) of petunia and the GASA (for GA-stimulated in Arabidopsis) gene family of Arabidopsis. GEG and GEG-like genes, the expression of which can also be induced by application of exoge-nous gibberellic acid (GA3) plays a role in phytohormone-mediated cell expansion. The use of a GEG-like gene for manufacturing plants having the capability of controlling the direction and dimensions of cell growth and altering the shape of plant cells and/or plant organs.
The term "spatiotemporal control" means that said GEG-like nucleic acid and their expression products are capable of controlling, i.e. regulating and/or adjusting the cell growth by alternatively, increasing and/or decreasing or inhibiting the cell growth in various directions, including longitudinal and/or radial direction with adjustable, advantageous time intervals.
The term "substantially homologous" means that the GEG-gene product have a homology of at least 40 % , preferably at least 50 % , most preferably at least 55 % at amino acid level.
The term "defined hybridization conditions" means any hybridization conditions varying between the conditions of 58 °C, 2xSSC and 58 °C, 0.2XSSC. The upper limit allows the capture of genes closely related with Gerbera and the lower limit of at least 58 °C, 0.2XSSC allows the capture of the GEG-gene as such, especially when the part of the nucleic acid sequence encoding the homologous C-terminal domain is excluded.
The term "plant cell line" means a cell line into which a GEG-like gene is inserted by per se known methods or is a cell line capable of expressing a GEG-like gene product having the capacity of controlling the direction and dimensions of cell growth, especially increasing the radial cell growth and inhibiting the longitudinal cell growth.
The term "transgenic plant" means a plant into the cells of which at least one GEG-like gene has been introduced or integrated and which cells are capable of expressing a GEG-like gene product having the capacity of controlling the direction and dimensions of cell growth. especially increasing the radial cell growth and inhibiting the longitudinal cell growth or vice versa.
The terms "GEG-like gene products and derivatives thereof" cover all possible splice variants of the GEG-product, including truncated, complexed as well as derivatized forms of said GEG-product, which still have the capacity of spatiotemporal control of cell growth in plants.
As a conclusion "GEG-like gene product" in its broadest aspect in the present invention, covers not only normal GEG-like molecules including their isc;,i'~~~~tns of different origin, as separate entities or in any combinations. The term covers all listed gene products in their active forms and in any combinations of said forms as well as fragmented, truncat-ed, derivatized and/or complexed forms thereof, which fulfill the prerequisites defined in the previous paragraph.
The term "isoform" refers to the different forms of the same protein, which originate from different sources, e.g. different species of plants. In the present invention the term includes fragments, complexes and their derivatives. For example, GEG-like gene products are generated e.g. by the cleavage. Different reactions, including different enzymatic and non-enzymatic reactions, proteolytic and non-proteolytic, are capable of creating a truncated, derivatized, complexed form of the said GEG-gene product. They are incorporated in the present invention as long as they fulfill the prerequisite of capacity for spatiotemporal control of plant cell growth.
The term "altering" means capacity of spatiotemporal control of plant cell growth, i.e.
adjusting by molecular regulation the direction and dimensions of cell growth and the organ shape in plants, especially during flower development.
The term "manufacturing plants with spatiotemporal control of cell growth"
means that the plants are transgenic plants produced by incorporating (inserting) a DNA-construct or vector carrying one or more nucleic acid sequences of the present invention into a plant cell, which can be induced to express said insert by administration of gibberellic acid (GA3) or auxin or is constitutively expressing said insert. Said plant cells are capable of spatiotemporally directing cell growth in variable directions in order to allow reshaping of organs in plants.
The GEG-like gene products expressed by the GEG-like nucleic acid sequences of the present invention zr-e, accordingly, useful for altering or adjusting the size and shape of plant cells or plant organs to its respective application.
The GEG-like nucleic acid sequence as well as their expression products can be used for manufacturing plant cells or plants with modifiable size and/or shape by directing the plant cell growth, in various, alternatively, in longitudinal and/or radial direction to obtain the size and shape of plant cells or plant organs, which is best suited to its respective application in agriculture, horticulture and/or forestry.
It is especially desirable if the longitudinal growth of plant cells is increased and allows the production of longer fibers for applications in pulp and paper industry, or production of longer floral stems in horticulture, or if the longitudinal growth of plant cells is decreased and allows production of crop plants with shorter stem and increased resistance and which prevents flattening of the crop in agricultural and horticultural applications.
The General Description of the Invention Recently, knowledge about the control of cell growth in plants has accumulated with increasing rapidity, but the molecular control of organ shape during flower development is still largely unknown. The GEG-like gene/protein family shares several features that may suggest a role for GEG in regulating cell expansion. The "GEG-like genes and their gene products", both novel and previously known, are useful for manufacturing plants having the capability of controlling the direction and dimensions of cell growth and altering the shape of plant cells and/or plant organs.
By using differential hybridization techniques, the present inventors isolated a cDNA des-ignated GEG (Gerbera hybrida homolog for the gibberellic acid stimulated transcript 1 [GASTI], from tomato) from a library representing late stages of corolla development in Gerbera hybrida. It was successfully shown that GEG expression in corollas and carpets coincides spatiotemporally with flower opening. In corollas and styles, GEG
expression is temporally correlated with the cessation of longitudinal cell expansion. In plants consti-tutively expressing GEG, reduced corolla lengths and carpets with shortened and radially expanded stylar parts with concomitant reduction of cell expansion in these organs was observed and in styles, an increase in radial cell expansion was detected.
Due to the high degree of regularity of flower organ shape, the present inventors assumed that it would be useful to study the basis of organogenesis in plants using molecular and genetic approaches. In gerbera (Gerbera hybrida: Asteraceae), the most prominent part of the corolla is the blade like ligule, which has resulted from a fusion of three petal lobes (Bremer, K, Asteraceae, Cladistics & Classification.
Portland, Timber Press, 1994; Helariutta, Y., et al., Plant Mol. Biol. 22, 183-193, 1993).
The styles of carpets are fine and elongated non-photosynthetic structures. By using differential hybridization of a corolla cDNA library a cDNA, GEG (for gerbera GASTI-like gene) was isolated and it was shown that GEG plays a role in the regulation of cell shape during corolla and carpet development in gerbera. GEG expression both spatially and temporally correlates with the opening of the corolla and with cessation of corolla elongation. In the carpet, induction of GEG expression coincides with the cessa-tion of style elongation. In transgenic plants constitutively expressing GEG, corollas are shorter when compared to those of non-transformed lines. Similar to the corolla, constitu-tive GEG expression causes shortening of the carpet, but also a concomitant radial expansion of the style. In the present invention it is shown that epidermal cells of both the ligular part of the corolla and the style are reduced in length along organ axes. Radial expansion of the epidermal cells in styles was also observed. The results suggest that said phytohormone mediated cell expansion also can be applied in agriculture and forestry in order to provide new methods and means for controlling plant growth in a desired direc-tion.
In a database search it was shown that GEG belongs to a gene family encoding putative small cell wall proteins with a cysteine-rich domain and a putative signal peptide sequence (GAST1 of tomato, GASA1-4 of Arabidopsis and GIP of petunia and RSI-1 of tomato) (Shi, L., et al., Plant J. 2, 153-159, 1992; Taylor, B. H., et al., Mol. Gen.
Genet. 243, 148-157, 1994; Herzog, M., et al. Plant Mol. Biol. 27, 743-752, 1995;
Ben-Nissan. G. , et al. , Plant Mol. Bio1.32, 1067-1074, 1996). GEG expression was experimentally induced by a treatment with gibberellic acid (GA3), which is similar to previous reports indicating that these genes are susceptible of being regulated by gibberellic acid or auxin. The results obtained indicate that GEG is pan of a phytohor-mone-mediated cell expansion mechanism that functions during corolla and carpel development and that mechanism can be used for developing new methods and means for providing plant raw materials with more desired and advantageous structure for agri-cultural and forestral applications.
The expression pattern of GEG correlates with completion of organ and cell elongation both in corollas and carpels. Furthermore, in transgenic plants, constitutive GEG expres-sion demonstrates that excessive GEG production is able to cause alterations in organ and cell shape during corolla and carpet development. This suggests that GEG plays a role in determining cell shape during carpet and corolla morphogenesis, thus providing function-al information for the role of GEG-like genes in plants.
In carpets, constitutive GEG expression reveals a negative interrelationship between longitudinal and radial growth. As described above, this is also evident in epidermal cells. However, in corollas, no radial expansion of epidermal cells, due to constitutive GEG expression, was observed. Furthermore, in carpets, no increase in style width was observed during endogenous GEG expression stage (Figure 4D). This would suggest that the primary role of GEG is to inhibit cell elongation. According to this hypothesis, con-stitutive GEG expression prematurely inhibits cell expansion in the longitudinal direc-tion. This could lead to growth potential of the cell to be directed passively in the radial direction as seen in the epidermal cells of the style. The alternative hypothesis that GEG
would promote radial and inhibit longitudinal expansion simultaneously is also possible.
In the present invention the dimensions of epidermal cells by scanning electron microsco-py has been measured and GEG expression was observed in the underlying parenchy-matic cells. This observation indicates that it is probable that analogous changes in cell shape can occur also in other plant cells The parallels between cell expansion and organ expansion are evident, although it is possible that in addition to cell expansion, cell divi-sion events could also contribute to the determination of the final shape at the stages analyzed.
The genes orthologous to GEG have been described earlier in various plants, e.g.
GASTI (tomato), GASAI-S (Arabidopsis), GIP (petunia), and RSI-1 (tomato) (Shi, L., et al. , Plant J. 2, 153-159, 1992; Taylor, B. H. , et al. , Mol. Gen. Genet.
243, 148-157, 1994; Herzog, M., et al. Plant Mol. Biol. 27, 743-752, 1995; Ben-Nissan, G., et al., Plant Mol. Bio1.32, 1067-1074, 1996).
The GEG-like gene/protein family shares several features that may suggest a role for GEG in regulating cell expansion. Based on our studies of GEG expression and the fact that several members (GEG, GASTI , and RSI-1 ) have been isolated based on a differential screening method, we can conclude that the mRNA is relatively abundant, characteristic of a structural role for the gene product. Furthermore, the putative signal sequence and the absence of other targeting signals suggest that the gene products are secreted, possibly to the cell wall (Shi, L. , et al. , Plant J. 2, 153-159, 1992). Another characteristic feature is regulation of gene expression with phytohormones.
The variability in the effective hormone indicates that the role of the genes may be downstream of various signal transduction pathways after their convergence.
Taken together with the data from transgenic plants suggesting that the primary role of GEG may be inhibiting axial cell expansion, it is possible that the GEG like function may be generally related to establishing cell wall properties during organogenesis in plants.
The present invention is further described in the following part in which the methodology and results are described in detail. These metl~a:,r~a as well as the results obtained should not be interpreted as restricting the scope of the protection.
Based on said description those skilled in the art can easily think of develop other equally well functioning desirable and advantageous applications for agriculture and forestry.
Example 1 Plant material Gerbera hybrida var Terra Regina used in this research was obtained from Terra Nigra BV, Holland. The control and transgenic plants were grown under identical conditions (side by side) at the same time and the age of plants was same. Developmental stages of the inflorescence are described in Helariutta, Y., et al., Plant Mol. Biol.
22, 183-193, 1993. For all analyses, samples were collected from outermost ray florets (flowers) of the inflorescence, and each transgenic and control plant sample was harvested and treated at the same time.
Example 2 Plant transformation Gerbera transformation was performed using Agrobacterium tumefaciens-mediated gene transfer as described previously (Elomaa, P., et al., Biotechnology 11, 508-511, 1993).
Transformation was verified by RNA blot analysis showing GEG expression in leaves and by DNA blot analysis. The analyses have been performed on clones of the original transgenic plants (TO).
Example 3 Isolation of plant DNA and RNA
Plant DNA was is~~lated using the methods by Dellaporta S. L., Plant Mol.
Biol. Rep.
l, 19-21, 1983. ~ :veal RNA was isolated as described in Jones, J. D. G., et al., EMBO
J. 4, 2411-2418, 1995 or by the Rneasy Plant total RNA kit (Qiagen, Chatsworth, CA).
Poly(A)+ RNA was isolated using oligo(dT) cellulose affinity chromatography (Sambrook, J., et al., Molecular Cloning: A Laboratory Manual., Cold Spring Harbor, NY: Cold Spring Harbor Laboratory, 1989).
Example 4 Construction and differential screening of a corolla cDNA library Polyadenylated RNA (5 ~,g), extracted from proximal part of ray floret corollas at devel-opmental stages from 5 to 9 (Helariutta, Y., et al., Plant Mol. Biol. 22, 183-193, 1993) was used to construct a cDNA library in the ZAPII vector (ZAP-cDNA synthesis kit;
Stratagene, La Jolla, CA). From the non amplified cDNA library, about 50.000 plaques were plated and transferred onto replica nylon membranes, and then screened differen-tially with radiolabeled first-strand cDNA pools from the ray floret tube region of the proximal part and distal part of ligule (first strand cDNA synthesis kit;
Amersham).
GEG cDNA was isolated as a clone which is expressed stronger in proximal part than distal part of the ligule. Two independent, but similar cDNA clones were isolated, sub-cloned into pUCl8 derivative, and sequenced using the AutoRead kit (Pharmacia, Uppsa-la, Sweden). The 813 by genomic fragment containing part of GEG promoter was ob-tained by applying a 5' RACE like PCR amplification on genomic DNA. The GEG
cDNA sequence and sequence of the 5' flanking region of the GEG gene have been submitted to EMBL database and the accession numbers are AJ005206 and AJ006273, re-spectively .
Example 5 RNA blot analyses and in situ hybridization Fifteen micrograms of total RNA was loaded per lane. The amount of RNA to be loaded was measured spectrophotometrically and the equal loading was confirmed by ethidium bromide staining of rRNA bands. The electrophoresis and hybridizations were made as described in Sambrook et al. , 1989. The 259-by long 3' fragment (of which 234 by is from non coding region) served as the probe. Washing conditions of 0.2 SSC (1 SSC
is 0.15 M NaCI and 0.015 M sodium citrate) and 0.1 % SDS, 58oC were applied in all RNA blots. In situ hybridization was carried out as described previously in Kotilainen M., et al., Plant Mol. Biol. 26, 971-978, 1994 using 35S-CTP-labeled antisense and sense (control) RNA probes. The probes were transcribed from the same fragment as used in the gel blot studies under the T7 promoter in vector pSP73 (SP6/T7 transcription kit; Roche Diagnostics, Mannheim Germany).
Example 6 Scanning electron microscopic analysis Corolla and carpet samples of control and transgenic plants were collected and further treated side by side at the same time. They were fixed in FAA buffer (50 %
ethanol, 5 acetic acid, and 2 % formaldehyde) overnight, and then transferred through ethanol series to 100 % ethanol, critical point dried (Balzers CPD 030 Critical Point Dryer, Bal-Tec, Liechtenstein) and coated with platinum/palladium (Agar Sputter Coater, Agar Scientific Ltd, UK). Specimens were mounted on aluminium stubs using graphite adhe-sive or tape. examined with scanning electron microscope (Zeiss Digital Scanning Micro-scope DSM 962, Karl Zeiss, Germany) in the Electron Microscopy Laboratory of the Institute of Biotechnology, University of Helsinki.
Example 7 Organ and cell measurements and statistical analysis Organ length and width measurements were done with vernier caliper in vivo, except for carpet width, which was measured from scanning electron micrographs 200 ~m below stigma. Cell length and width were measured by using scanning electron micrographs.
To study whether the differences in organ and cell expansion caused by constitutive GEG
expression are statistically significant, Student s t tests and/or Rank sum tests were per-formed. Parametric t test was used if the normality and the equal variances of samples were confirmed (P values to reject < 0.050). Non parametric Rank sum test was used if either was not confirmed. The level of confidence is P < 0.001 in all statistically signifi-cant differences mentioned in this study.
Example 8 Isolation of GEG cDNA by differential screening Both spatially restricted anthocyanin pigmentation patterns Putative signal sequence and the absence of other targeting signals suggest Another characteristic feature is regulation of gene expression with phytohormones. The variability in the effective hormone indicates that the role of the genes may be downstream of various signal transduction pathways after their convergence. (Helariutta, Y., et al., Plant Mol. Biol.
22, 183-193, 1993) and gene product accumulation patterns (Helariutta, Y. , unpublished) in various regions of the gerbera ray floret corolla indicate region-specific control of gene expression along the longitudinal axis of the corolla. We performed several differential screening schemes along this axis during the late stages of corolla morphogenesis to isolate genes with differential expression within the corolla. In this context, we isolated a cDNA as a clone whose expression is stronger in the proximal part of the corolla than in the distal part. Based on high similarity to GASTI-like genes, we have named this cDNA
GEG.
Sequence comparisons show that GEG belongs to a family of genes that are transcrip-tionally regulated by phytohormones in different plants. The predicted GEG
protein has high sequence similarity with proteins encoded by genes whose expression is induced by gibberellic acid (GASTI of tomato, GASAI-4 of Arabidopsis, and GIP of petunia) or by auxin (RSI-1 of tomato) (Shi, L. , et al. , Plant J. 2, 153-159, 1992; Taylor.
B. H. , et al. , Mol. Gen. Genet. 243, 148-157, 1994; Herzog, M., et al. Plant Mol. Biol. 27, 743-752, 1995; Ben-Nissan, G., et al., Plant Mol. Bio1.32, 1067-1074, 1996).
All of the derived polypeptides have a putative signal sequence at their N termini, with cleavage sites predicted according to von Heijne, G. , Nuclear acid research 14, 4683-4690, 1986.
Because other targeting signals have not been identified, it has been proposed that these gene products are targeted into the extracellular space or into the cell wall.
Among 60 C-terminal amino acids, there are 22 identical residues of which 12 are cysteines.
During DNA gel blot analysis, the probe (a 259-by long 3' fragment of the GEG
cDNA, 90% noncoding) recognized one or two bands at the stringency used for RNA gel blot-ting. This most probably indicates that the expression analysis results presented below correspond to transcription of a single locus, and that the two bands found in some di-gests were due to restriction length polymorphism in the heterozygous cultivar. During low stringency DNA gel blot analysis, the full-length GEG cDNA probe recognized more bands, suggesting that there is a small gene family of GEG-like genes in the ger-bera genome (data not shown).
Example 9 GEG mRNA is abundant in corollas and carpets The developmental expression pattern of GEG was studied by using RNA gel blot analy-ses. The expression of GEG is highest in floral organs, in addition a faint signal was detected in RNA from leaf blades. Strong GEG expression was observed in corolla tissue (both tube and ligule regions) and carpets, with more moderate signals in the scape (flo-ral stem) and the receptacle (terminal enlargement of floral stem) (Figure 1 ) . To under-stand the role of GEG in plant development, we focussed on GEG expression in corolla and carpet.
GEG expression was studied temporally at different stages of ray floret corolla develop-ment (Figures 2A to 2F, and Helariutta, Y., et al., Plant Mo?. l3iol. 22, 183-193, 1993.
The expression correlates temporally with opening of both individual florets and the whole inflorescence, being induced at stage 7 (Figure 2G). Because of the large size of ray floret corollas in gerbera, we were able to isolate RNA from various parts of the corolla over time and study the developmental induction pattern of GEG
expression by using RNA gel blot analysis. The pattern is intriguing. Just prior to the opening of the flower - and unfolding of the corolla - the onset of GEG expression occurs almost simultaneously from both ends of the corolla. The very first signal can be seen in the proximal part of the corolla, more precisely in the joint region of tube and ligule (Figure 2H: stage 7). During opening, the proximal expression proceeds in both directions:
basipetally into the tube and acropetally into the ligule. Almost simultaneous to the onset of proximal expression, GEG expression also starts from the distal end of the corolla.
This expression proceeds basipetally towards the middle of the ligule, where both proximal and distal expression domains meet just as the corolla has opened (Figure ZH:
stage 8). GEG expression continues at a high level until senescence takes place (data not shown). Ih situ hybridization analysis of GEG expression pattern revealed that the transcript can be detected both in the mesophyll and in the epidermis during opening of the corolla (Figure 3B).
In carpets, GEG expression was studied by gel blotting using RNA from samples taken before and after the opening of ray florets at developmental stages 6 and 8, respectively (Figures 2C to 2F and Helariutta, Y., et al., Plant Mol. Biol. 22, 183-193, 1993). As shown in Figure 2G, the onset of GEG expression coincides with the opening of the florets. In the style, GEG mRNA was detected in the outer epidermis and in parenchyma (cortex), but not in transmitting tissues (Figure 3A).
Example 10 Temporal correlatian of GEG expression with cessation of organ and cell elongation in corollas and c.;ay gels Biometric analyses (Figure 4) of corolla growth show that before its opening, the corolla expands both longitudinally and laterally. Soon after opening, growth ceases in both directions (Figures 4A and 4B). Temporally, GEG expression follows tightly the cessa-tion of corolla growth, and is detected everywhere in corolla tissues just after opening (Figure 2D to 2F, and 2H).
The temporal GEG expression pattern along the apical-basal axis of corolla made it important to analyze whether GEG expression correlates with cessation of cell elonga-tion. Cell length was measured in the distal and central regions of corolla (Figure 2H, regions 7 and 5, respectively) just after stage 7 (7+) and at stage 8. At these stages, GEG mRNA is present in the distal region, but reaches the central region just prior the stage 8 (Figure 2H).Cell length measurements revealed that cells in the distal region do not elongate, whereas in the central region, axial cell elongation takes place (Figure SA).
The cell length differences between stage 8 middle cells and other groups are statistically significant (Rank sum tests, P < 0.001). Cell width growth was detected both in distal and middle parts of corolla between stages 7 + and 8 (Figure 5 B) . Thus, GEG
expression strictly correlates with the cessation of cell expansion along the apical-basal axis.
Similar to corolla, carpet organogenesis was characterized in more detail using biometric analyses (Figure 4). Carpet length and width in the outermost ray florets were measured at various stages of inflorescence development. The opening of ray floret corollas and the whole inflorescence coincides with a change in the longitudinal expansion of carpets.
Elongation of the carpets takes place before the opening of the floret, being most rapid just prior to the opening. After opening, the elongation of carpets has ceased (Figures 2F
and 4C). In the radial direction, the styles do not expand statistically during the elonga-tion period or later (Figure 4D). Thus, in carpets the cessation of elongation is also temporally correlated with GEG expression.
Cell elongation coincides with the patterns described in organs, the epidermal cells of the style elongate before the opening of the floret but not later (Figure 4E).
Therefore, cell elongation, at least to a large degree, is responsible for the observed carpet growth de-scribed above. In both corollas and carpets, GEG expression correlates temporally with cessation of cell expansion along the apical-basal axis.
Example 11 Transgenic plants that overexpress GEG have shorter corollas Detailed temporal analysis of the developmental regulation of GEG shows that its tran-scription correlates with cessation of cell elongation both in the corolla and in the carpet.
Based on this observation, we hypothesized that the functional role of the GEG
polypep-tide is to suspend cell elongation. To test this hypothesis, we generated transgenic plants in which GEG expression was under the control of a constitutively active promoter. In these plants, constitutive GEG expression should lead to premature inhibition of cell elongation. and to shorter organs with shorter cells.
The GEG cDNA was introduced into gerbera plants under regulation of the Cauliflower mosaic virus 35S promoter via Agrobacterium tumefaciens-mediated transformation.
Four constitutively GEG-expressing lines were generated, and analyses of both the length and the width of 20 outermost ray floret corollas in four transgenic plants and control plants were conducted at developmental stage 9 when corolla growth has ceased.
All four lines constitutively expressing GEG (ml, m3 , m2, and m5) have shorter corollas when compared to the non transformed line and the two control lines transformed with GEG in an antisense orientation, resulting in no or modest decline in GEG expression (Figures 6 and 7A; antisense lines with significantly reduced GEG expression levels were not ob-tained). The differences are statistically significant (t test/Rank sum test;
P < 0.001). In contrast, the corolla width in all plants of lines constitutively expressing GEG lines re-mained unchanged when compared to control lines (Figure 7B).
Example 12 Constitutive expression of GEG decreases cell length in corollas More detailed analyses of corolla and carpet phenotypes were performed with two trans-genic lines ml and m3 together with a non transformed control line as presented below.
Constitutive expression of GEG in these transformants was verified by in situ hybridiza-tion of corolla cross-sections at developmental stage 6, when endogenous GEG
expres-sion is not yet present and by RNA gel blot analysis of leaf tissues where the endogenous expression is very low. In situ analyses show that all cell types overexpress GEG (data not shown).
In the corolla of both ml and m3 lines together with the control line, the length and the width of epidermal cells were measured at the central part of the proximal end of the ray floret corolla ligules on their adaxial sides at developmental stage 8 (Figure 8A). In plants constitutively expressing GEG, cell length was reduced in a statistically significant manner (t test; P < 0.001) but no difference in cell width could be measured (Figures 8B, 8C, 9A, and 9B). As a conclusion, the major impact of constitutive GEG
expression is the cessation of the axial cell expansion of epidermal cells in the ligule.
Example 13 Epidermal cells of the style are shorter and wider in lines constitutively expressing GEG
Compared to the control line, transgenic lines constitutively expressing GEG
has a de-crease in carpet length and an increase in carpet radius (Figures 10, 11A, and 11B). A
comparison of cell length and the width of style epidermal cells between ml and m3 lines constitutively expressing GEG, and the control line revealed a change in elongation pattern. Even before endogenous expression, at stage 6, statistically significant changes of cell length and width could be detected (t test; P < 0.001). In ml and m3 lines constitu-tively expressing GEG, cell length was reduced and the width was increased compared to control line (Figures 10, 11C, and 11D). The constitutive expression phenotypes support the view that the GEG gene product regulates cell expansion in the axial dimension during carpet development as well as during corolla development. However, in the carpet, unlike in the corolla, we observed a concomitant opposite effect in the radial dimension.
Example 14 Gibberellic acid and regulation of GEG expression in the corolla Because all of the homologous genes (see Introduction) are induced by phytohormones and because expression is spatially and temporally regulated, we studied whether GEG
expression reacts to GA3. Exogenous GA3 application upregulated GEG expression in ray floret corollas of detached inflorescences (Figure 12). A short pulse of GA3 was able to induce GEG in 2 hrs. However, because maximal levels of GEG mRNA were seen not before than 24 hrs after GA3 application, it is possible that GA
stimulation of GEG
expression is indirect or decline of gibberellic acid concentration (rather than increase) induces GEG expression.
We have also isolated the genomic 5' flanking sequence of GEG. It contains two sequence motifs that are found in the flanking regions of rice and barley -amylase genes whose expression is regulated by gibberellic acid (Huang, N. , et al. . Plant Mol. Biol.
14, 655-668, 1990; Skriver, K., et al., Proc. Natl. Acad. Sci. USA 88, 7266-7270, 1991. This further supports the idea that GEG expression is developmentally regulated by gibberellic acid.
Figure 1. RiVA gel blot hybridisation analysis showing the tissue specificity of GEG
expression.
Autoradiography of an RNA gel blot probed with a 259-by lo:ug 3' fragment of the GEG
cDNA (90 % noncoding). Fifteen micrograms of total RNA was loaded per lane and equal loading was confirmed by ethidium bromide staining. Organs covering several developmental stages were examined. Scape, floral stem; receptacle, terminal enlarge-ment of floral stem.
Figure 2. Analysis of GEG expression during corolla and carpet development.
(A) to (F) Different developmental stages of gerbera inflorescence, according to Helariut-ta et al. (1993).
(A) The developmental stage is 1, (B) 3, (C) 5, (D) 7, (E) 7.5, and (F) 8.
(G) The expression of GEG in carpet and corolla correlates with opening of both individ-ual ray florets and the whole inflorescence.
Spatial partition of ray floret corolla. Regions are indicated above the gel.
The onset of expression occurs from both ends of the corolla (stage 7, regions 2 and 7) and just as the corolla has opened. Both expression domains meet at the middle of the ligule (stage 8, region 5). Region 1 is the tubular part of ray floret corolla (tube); region from 3 (proxi-mal region) to 7 (distal region) represent the ligular part of the corolla.
GDFRI is used as a loading control. The developmental stages are the same as presented in (A) to (F).
Figure 3. Analysis of GEG expression in carpet and corolla by in situ hybridization.
In both organs (stage 7.5), GEG expression is seen in epidermal and parenchymatic cells as white silver grains. In situ analysis were carried out using the 35S-CTP-labeled an-tisense and sense (control, data not shown) RNA probes. The probes were transcribed from the same 3' fragment of GEG cDNA as used in RNA gel blot analysis.
(A) Cross-section e;' carpet style.
(B) Cross-section: c:~ marginal region of proximal part of corolla ligule.
Bar = 100 ~cm for (A) and (B).
Figure 4. Biometric analysis of corolla and carpet length and width development.
(A) and (B) Corolla length and width, respectively: Temporal GEG expression tightly follows the cessation of corolla expansion in both longitudinal and lateral directions (see also Figure 2) .
(C) Carpet length: In the carpet, cessation of elongation temporally correlates with GEG
expression.
(D) Carpet width: The carpet styles do not expand in radial direction during the elonga-tion period or later.
(E) Carpet cell length: In carpet the epidermal cells of style elongate before opening of the floret but not later, thus the retardation of cell elongation correlates with GEG expres-sion.
Timing of different developmental stages (described in Helariutta, Y. , et al.
, Plant Mol.
Biol. 22, 183-193, 1993) was measured by following the development more than inflorescences under our standard greenhouse conditions. The lengths and widths of both corolla and carpet, shown in (A) to (D), were measured from 15 to 30 outermost ray florets at each developmental stage. Samples were collected at least from two different inflorescences. Carpet cell length (E) of 72 epidermal cells of each time point was measured. Cell lengths of 18 epidermal cells 200 - 400 ~.m below the stigma of each car-pet were determined, and the average cell length of four carpets was measured.
Numbers below the curves correspond to the developmental stages of inflorescence (see Figures 2A to 2F). Error bars indicate the standard deviation.
Figure 5. Cell length and width in distal and central regions of ray floret corolla just prior and after the opening (stages 7+ and 8, respectively).
GEG is expressed in proximal part at both stages, whereas GEG expression reaches the central region just prior the stage 8 (see Figure 2H).
(A) Corolla cell length in microns. The cells in distal region do not elongate, whereas the cells in central region elongate. Thus, GEG expression strictly correlates with cessa-tion of cell expansion along the apical-basal axis. Tip, distal region; Mid, central region.
(B) Cell width (~,m) growth was detected both in distal and central regions of corolla.
Cell length and width were measured with vernier caliper using scanning electron micro-graphs. The length of forty cells in three distinct ray floret corollas each was measured at each point. At distal region of corolla the measurements were done at 1 mm from the tip. Cell widths were measured by counting cell numbers on 36 of 570 ~,m long trans-verse lines and counting the average cell widths of each line. Error bars indicate the standard deviation.
Figure 6. Comparison of the ray floret corollas of a non transformed line (wt) with that of an m3 plant constitutively expressing GEG before (stage 7), during (7.5), and after (9) the opening of ray florets.
Figure 7. Analysis of corolla length and width for four lines constitutively expressing GEG and the control lines.
(A) Corolla length (mm). Length of the outermost ray floret corollas of wild-type, consti-tutively GEG expressing lines (ml, m3, m2, and m5), and two GEG antisense lines with no (t4) or a modest (t9, 80% remaining) decline of GEG expression. All four lines con-stitutively expressing GEG have statistically shorter corollas compared to the control lines.
(B) The corolla width (mm) of all lines constitutively expressing GEG remained unchanged when compared to control lines.
Forty outermost ray floret corollas of two inflorescences of each line at stage 9 were collected. Corolla width and length of four lines constitutively expressing GEG (ml, m3, m2, and ms), a non transformed line and two antisense lines (with no or modest effect in GEG expression) were measured. Error bars indicate the standard deviations.
Figure 8. Analysis of the effects of constitutive GEG expression on corolla epidermal cells.
(A) The epidermal cells are organized into longitudinal files running along the apical-bas-al axis of corolla.
(B) Scanning electron microscopy of the adaxial (upper) side of proximal part of ray floret corolla of a non transformed control line (stage 8). The area in (B) is marked with a white box in (A). One of the epidermal cells is highlighted.
(C) Scanning electron microscopy of the corresponding region of an ml line constitutive-ly expressing GEG. Bar in (C) = 75 ,um for (B) and (C).
Figure 9. Cell lengths and widths in the same regions as described in Figure 8 of ml and m3 lines constitutively expressing GEG and a control line (wt). In plants constitutively expressing GEG, cell length was reduced but no difference in cell width could be mea-sured.
(A) Corolla cell length in microns. The cell lengths in these two lines constitutively expressing GEG are shorter when compared to control and the differences are statistical-ly significant.
(B) Corolla cell width in microns. Cell widths of these lines constitutive expressing GEG
did not differ from that of a control line.
Three ray floret corollas of transgenic lines ml and m3 together with a non transformed control line were collected (stage 8), and cell length and width were measured at the region marked with a white box in the Figure 8A. In corollas, transverse lines were drawn on micrographs, and cells were chosen at intervals of 1 cm for length measure-ments. Cell length of about 200 cells were measured of ml, m3, and a control line. Cell width was measured by counting cell numbers on 30 - 36 of 570 ~.m transverse lines and counting the average cell width of each line (approximately 40 cells per line).
Figure 10. Scanning electron microscopy of the epidermis of stylar part of the carpet 300 m below the stigma. In an ml line constitutively expressing GEG, cell length was reduced and the width was increased compared to control line.
(A) A non transformed control line and, (B) an ml line constitutively expressing GEG at stage 6. Bar = 100 ~,m for (A) and (B).
Figure 11. Analysis of the effects of constitutive GEG expression on epidermal cells of the carpet style.
(A) Carpet length in millimeters. Carpet length of lines constitutively expressing GEG is shorter when compared to a control line.
(B) Carpet width in microns. Compared to a control line, carpet radius has increased in lines constitutively expressing GEG.
(C) Carpet cell length in microns. Comparison of cell length of ml and m3 to a non transformed control line reveals that epidermal cells of style of lines constitutive express-ing GEG are shorter when compared to a control line.
(D) Carpet cell width in microns. The epidermal cells of constitutively GEG
expressing lines are wider when compared to a control line.
Twelve to twenty carpets of two lines constitutively expressing GEG (ml and m3) and a non transformed control line were measured. Carpet length was measured at developmen-tal stage 9; carpet width, epidermal cell length, and width were measured at stage 6. Cell length of 18 individual epidermal cells 200 - 400 ~,m below the stigma of each carpet and the average cell length of 12 - 20 carpets of each line were measured. The differences presented in (A), (B), (C) and (E) are statistically significant. Error bars indicate the standard deviations.
Figure 12. Exogenous gibberellic acid application upregulates GEG expression in ray floret corollas RNA gel blot showing GEG expression after the addition of GA3 just before the opening of the inflorescence (stage 7+). The scape (floral stem) was cut 5 cm below inflores-cence.
(A) The control inflorescences were grown on 50 mM sucrose.
(B) Induction of GEG expression was detected when inflorescences were grown on mM sucrose with 5 ~,M GA3.
(C) Induction of GEG expression was also detected when infl~>-:e.~~;;:ences were first incu-bated in 50 mM sucrose with 50 ~,M GA3 for 5 min, and then transferred to 50 mM
sucrose medium.
Approximately 10 ray floret corollas were collected for RNA isolation at each time point (hours) after GA3 addition.
SEQUENCE LISTING
(1) GENERAL INFORMATION:
(i) APPLICANT:
(A) NAME: TEERI, Teemu, et al.
(B) STREET: Biotekniikan instituutti, Viikinkaari 9 (C) CITY: Helsinki, Helsingin yliopisto (D) STATE: Viikin biokeskus (E) COUNTRY: FINLAND
(F) POSTAL CODE (ZIP): FIN-00014 (G) TELEPHONE: 358-9-70859423 (H) TELEFAX: 358-9-70859570 (ii) TITLE OF INVENTION: METHODS AND GENE PRODUCTS FOR PZTERING
THE SHAPE OF CELLS AND ORGPNS IN PLANTS
(iii) NUMBER OF SEQUENCES: 5 (iv) COMPUTER REP.DABLE FORM:
(A) MEDIUM TYPE: Floppy disk (B) COMPUTER: IBM PC compatible (C) OPERATING SYSTEM: PC-DOS/MS-DOS
(D) SOFTWARE: PatentIn Release #1.0, Version #1.30 (EPO) (2) INFORMATION FOR SEQ ID NO: l:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 60 amino acids (B) TYPE: amino acid (C) STRANDEDNESS:
(D) TOPOLOGY: linear (ii) MOLECULE TYPE: protein (v) FRAGMENT TYPE: C-terminal (vi) ORiGIN.~L SOURCE:
(A) ORGANISM: Gerbera hybrida (xi) SEQUENCE DESCRIPTION: SEQ ID N0: 1:
Asn Cys Gly Ala Ala Cys Lys Ala Arg Cys Arg Leu Ser Ser Rrg Pro Asn Leu Cys His Arg Ala Cys G1y Thr Cys Cys Ala Arg Cys Arg Cys Val Pro Pro Giy Thr Ser Gly Asn Gln Lys Va1 Cys Fro Cys Tyr Tyr Asn Met Thr Thr His Gly Gly Arg Arg Lys Cys Pro (2) INFORMATION FOR SEQ ID N0: 2:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 101 amino acids (B) TYPE: amino acid (C) STRANDEDNESS:
(D) TOPOLOGY: linear (ii) MOLECULE TYPE: protein (xi)SEQUENCE DESCRIPTION: NO: 2:
SEQ ID
Met A1a Ile Ser Lys Pro Phe Ala Phe Ala Leu Leu Ser Met Leu Leu Leu Leu Leu G1n Leu Gly Gln Tyr Glu Met Val Asn Lys Ile Ala Asp Glu Ala Thr Ile Ala Ala Ser Lys Ile Asn Cys G1y Ala A1a Cys Lys AlaArg Cys Arg Ser Arg Pro Asr_ Leu Cys His A1a Leu Ser Arg Cys GlyThr Cys Cys Arg Arg Cys Va1 Pro Pro Gly ,Ser Ala Cys Thr Gly AsnGln Lys Val Pro Tyr Tyr Asn Met Thr Thr G1y Cys Cys His Gly Arg Arg Lys Cys Pro (2) INFORMATION FOR SEQ ID NO: 3:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 552 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: cDNA
(xi) SEQUENCE DESCRIPTION: SEQ ID N0: 3:
CTTCTTCTTC TCCAACTTGG TCPAGCTTAT GAA_ATGGTGA ACAAGATTGA TGAGGCGACC 120 ATCGCTGCTT CCP.APATCAR TTGTGGAGCA GCATGTAAGG CCAGGTGCCG GTTATCGTCG 180 AGGCCAP_ACT TGTGCCACAG GGCATGTGGG ACCTGTTGTG CCCGTTGCAG ATGCGTGCCA 2S0 TTACACP.ATA AAAAGTTGTG AARTAAATTG AATTTTATGC TTGTTAAAAG TTTP_AA.P.AAA 540 AAAAAAP~AA.A AA 5 5 2 (2) INFORMATION FOR SEQ ID N0: 4:
( i ) SEQUENCE CHAR.A.CTERISTICS
(A) LENGTH: 832 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: double (D) TOPOLOGY: linear (ii) MOLECULE TYPE: other nucleic acid (A) DESCRIPTION: /desc = "promoter"
(xi) SEQUENCE DESCRIPTION: SEQ ID N0: 4:
AATCAATCTT TGTAGGGAGC~AATTTAGGAT AGTTTAGTTC AGTATATGTC AATATATCTG 60 ATCGTTTGAG AAAA.~AAGGA TA_ATAAAGAC GATAATATTC TTTATTTTCC GACCTAAAGA 120 GTTAGGTAAG TTATAATTTA CTTTF.ATCGC TCGGTGTTTA ATGAAATATT ATATCCAAGT 180 CTCGACTCTC AATAAGTGTT AACATCTTTT TAGGTCGTAT TTGCTTACCA AAA.A.ACCTA.A 240 TTACAATATC ATGGTTATCA AP.AAATA.'~TA TCTTCTCTTG TTATTCTTTC GTGAAAACTA 360 CCGTTCCACT GTTACATACT GGATAGTACA TTTTATCAAC CATTCCGCTG TCACAA.A.A.AA 480 p~ZlA ATTAATACCG TCTTTTTAA.~ AGTCGATP.PA AAGGATAACA AGGATAACAA 540 CCGTTTP.ATC ATCAAATTAT TTGCAGTT.zIA GAGGTCATGA GAGATATCAT CCTAGCTAAA 600 TGCTTTTAGG TGAAACTCTT GTGGTGTCAA TAACATTTAA ATTTATAAAG AAP..AAGAGAA 660 ATTATTAAAA TCTTP.AATTG TTTTTTTCAA AAAGAGAAAT TATTAAAATC TTAAATTGTT 720 TTTTTCTTCT TATP.ATTATT ATTGACTCTC TTTCTTTGTC TATAP.ATAGG ATGC_~AGTCT 780 CCAACCTTAG GCACAPACTC AACCCAAPAC AAAG.~AAGTG TAGTCATAAG CC 832 (2) INFORMATION FOR SEQ ID NO: 5:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 180 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (A) DESCRIPTION: /desc = "3' end of the cDNA"
(xi) SEQUENCE DESCRIPTION: SEQ ID N0: 5:
AATTGTGGAG CAGCATGTAA GGCCAGGTGC CGGTTATCGT CGAGGCCAAA CTTGTGCCAC 60 , AGGGCATGTG GGACCTGTTG TGCCCGTTGC AGAT'GCGTGC CACCGGGTAC TTCCGGTAAC 120 CAAA.AGGTTT GCCCTTGCTA CTACAACATG ACCACCCATG GTGGCAGAAG AAAGTGCCCT 180
The term "GEG" for "~erbera GASTI-like gene" means an isolated and essentially purified cDNA sequence (Gerbera hybrida homolog for the gibberellic acid stimulated transcript 1 [GASTI], from tomato) obtainable from a library representing late stages of corolla development in Gerbera hybrida.
The term "GEG-like nucleic acid sequences" means nucleic acid sequences homologous to said GEG-gene or cDNA. The "GEG-like nucleic acid sequences" are characterized by a nucleic acid sequence encoding "GEG-like gene products" having an amino acid sequence substantially homologous with the C-terminal domain (SEQ ID NO:1: ) of the gene product of GEG (SEQ ID N0:2:). Said °'GEG-like nucleic acid sequences" are further substantially similar at nucleotide level with the GEG cDNA (SEQ ID
N0:3:). In its broadest aspect GEG-like nucleic acid sequences include the GEG-promoter SEQ ID
N0:4: as well as substantially homologous promoters, which are capable of directing a foreign gene or a heterologous nucleic acid sequence in the same way as GEG is directed by its native promoter in corolla and styles.
Said "GEG-like nucleic acid sequences" are further characterized by the capacity of spatiotemporal controlling of the plant cell growth by alternatively increasing and/or decreasing the cell growth in various directions or by directing said function.
Typical examples of such GEG-like nucleic acid sequences include isolated, essentially purified nucleotide sequences obtainable, for example, by differential hybridization from a group of plant genes having a high similarity with the GEG cDNA from Gerbera hybrida.
The term "DNA construct for altering the size and shape of plant cells or plant organs"
means any suitable vectors and/or DNA constructs comprising at least one GEG-like nucleic acid sequences combined with optional promoters, enhancers, signal sequences for inserting, targetting, controlling the size and shape of plants cells and plant organs.
The term "GEG gene product" means an amino acid sequence with the deduced amino acid sequence (SEQ ID N0:2:) sharing a high similarity with previously characterized putative cell wall proteins encoded by GEG-like nucleic acid sequences. The "GEG-like gene products" are polypeptides characterized by having an amino acid sequence comprising amino acid sequences substantially homologous with SEQ ID N0:2:, which are further characterized by having a highly conserved C-terminal domain, with one or more invariable cysteine residues. The "GEG-like gene products" are further characterized by the capacity of spatiotemporal control of cell growth, which can be determined by methods disclosed in the examples.
The term "GEG-like gene products" include in addition to said GEG-gene product, products obtainable by constitutive or induced expression of gibberellic acid-inducible genes, namely GAST1 of tomato, GIP (for gibberellin-induced gene) of petunia and the GASA (for GA-stimulated in Arabidopsis) gene family of Arabidopsis. GEG and GEG-like genes, the expression of which can also be induced by application of exoge-nous gibberellic acid (GA3) plays a role in phytohormone-mediated cell expansion. The use of a GEG-like gene for manufacturing plants having the capability of controlling the direction and dimensions of cell growth and altering the shape of plant cells and/or plant organs.
The term "spatiotemporal control" means that said GEG-like nucleic acid and their expression products are capable of controlling, i.e. regulating and/or adjusting the cell growth by alternatively, increasing and/or decreasing or inhibiting the cell growth in various directions, including longitudinal and/or radial direction with adjustable, advantageous time intervals.
The term "substantially homologous" means that the GEG-gene product have a homology of at least 40 % , preferably at least 50 % , most preferably at least 55 % at amino acid level.
The term "defined hybridization conditions" means any hybridization conditions varying between the conditions of 58 °C, 2xSSC and 58 °C, 0.2XSSC. The upper limit allows the capture of genes closely related with Gerbera and the lower limit of at least 58 °C, 0.2XSSC allows the capture of the GEG-gene as such, especially when the part of the nucleic acid sequence encoding the homologous C-terminal domain is excluded.
The term "plant cell line" means a cell line into which a GEG-like gene is inserted by per se known methods or is a cell line capable of expressing a GEG-like gene product having the capacity of controlling the direction and dimensions of cell growth, especially increasing the radial cell growth and inhibiting the longitudinal cell growth.
The term "transgenic plant" means a plant into the cells of which at least one GEG-like gene has been introduced or integrated and which cells are capable of expressing a GEG-like gene product having the capacity of controlling the direction and dimensions of cell growth. especially increasing the radial cell growth and inhibiting the longitudinal cell growth or vice versa.
The terms "GEG-like gene products and derivatives thereof" cover all possible splice variants of the GEG-product, including truncated, complexed as well as derivatized forms of said GEG-product, which still have the capacity of spatiotemporal control of cell growth in plants.
As a conclusion "GEG-like gene product" in its broadest aspect in the present invention, covers not only normal GEG-like molecules including their isc;,i'~~~~tns of different origin, as separate entities or in any combinations. The term covers all listed gene products in their active forms and in any combinations of said forms as well as fragmented, truncat-ed, derivatized and/or complexed forms thereof, which fulfill the prerequisites defined in the previous paragraph.
The term "isoform" refers to the different forms of the same protein, which originate from different sources, e.g. different species of plants. In the present invention the term includes fragments, complexes and their derivatives. For example, GEG-like gene products are generated e.g. by the cleavage. Different reactions, including different enzymatic and non-enzymatic reactions, proteolytic and non-proteolytic, are capable of creating a truncated, derivatized, complexed form of the said GEG-gene product. They are incorporated in the present invention as long as they fulfill the prerequisite of capacity for spatiotemporal control of plant cell growth.
The term "altering" means capacity of spatiotemporal control of plant cell growth, i.e.
adjusting by molecular regulation the direction and dimensions of cell growth and the organ shape in plants, especially during flower development.
The term "manufacturing plants with spatiotemporal control of cell growth"
means that the plants are transgenic plants produced by incorporating (inserting) a DNA-construct or vector carrying one or more nucleic acid sequences of the present invention into a plant cell, which can be induced to express said insert by administration of gibberellic acid (GA3) or auxin or is constitutively expressing said insert. Said plant cells are capable of spatiotemporally directing cell growth in variable directions in order to allow reshaping of organs in plants.
The GEG-like gene products expressed by the GEG-like nucleic acid sequences of the present invention zr-e, accordingly, useful for altering or adjusting the size and shape of plant cells or plant organs to its respective application.
The GEG-like nucleic acid sequence as well as their expression products can be used for manufacturing plant cells or plants with modifiable size and/or shape by directing the plant cell growth, in various, alternatively, in longitudinal and/or radial direction to obtain the size and shape of plant cells or plant organs, which is best suited to its respective application in agriculture, horticulture and/or forestry.
It is especially desirable if the longitudinal growth of plant cells is increased and allows the production of longer fibers for applications in pulp and paper industry, or production of longer floral stems in horticulture, or if the longitudinal growth of plant cells is decreased and allows production of crop plants with shorter stem and increased resistance and which prevents flattening of the crop in agricultural and horticultural applications.
The General Description of the Invention Recently, knowledge about the control of cell growth in plants has accumulated with increasing rapidity, but the molecular control of organ shape during flower development is still largely unknown. The GEG-like gene/protein family shares several features that may suggest a role for GEG in regulating cell expansion. The "GEG-like genes and their gene products", both novel and previously known, are useful for manufacturing plants having the capability of controlling the direction and dimensions of cell growth and altering the shape of plant cells and/or plant organs.
By using differential hybridization techniques, the present inventors isolated a cDNA des-ignated GEG (Gerbera hybrida homolog for the gibberellic acid stimulated transcript 1 [GASTI], from tomato) from a library representing late stages of corolla development in Gerbera hybrida. It was successfully shown that GEG expression in corollas and carpets coincides spatiotemporally with flower opening. In corollas and styles, GEG
expression is temporally correlated with the cessation of longitudinal cell expansion. In plants consti-tutively expressing GEG, reduced corolla lengths and carpets with shortened and radially expanded stylar parts with concomitant reduction of cell expansion in these organs was observed and in styles, an increase in radial cell expansion was detected.
Due to the high degree of regularity of flower organ shape, the present inventors assumed that it would be useful to study the basis of organogenesis in plants using molecular and genetic approaches. In gerbera (Gerbera hybrida: Asteraceae), the most prominent part of the corolla is the blade like ligule, which has resulted from a fusion of three petal lobes (Bremer, K, Asteraceae, Cladistics & Classification.
Portland, Timber Press, 1994; Helariutta, Y., et al., Plant Mol. Biol. 22, 183-193, 1993).
The styles of carpets are fine and elongated non-photosynthetic structures. By using differential hybridization of a corolla cDNA library a cDNA, GEG (for gerbera GASTI-like gene) was isolated and it was shown that GEG plays a role in the regulation of cell shape during corolla and carpet development in gerbera. GEG expression both spatially and temporally correlates with the opening of the corolla and with cessation of corolla elongation. In the carpet, induction of GEG expression coincides with the cessa-tion of style elongation. In transgenic plants constitutively expressing GEG, corollas are shorter when compared to those of non-transformed lines. Similar to the corolla, constitu-tive GEG expression causes shortening of the carpet, but also a concomitant radial expansion of the style. In the present invention it is shown that epidermal cells of both the ligular part of the corolla and the style are reduced in length along organ axes. Radial expansion of the epidermal cells in styles was also observed. The results suggest that said phytohormone mediated cell expansion also can be applied in agriculture and forestry in order to provide new methods and means for controlling plant growth in a desired direc-tion.
In a database search it was shown that GEG belongs to a gene family encoding putative small cell wall proteins with a cysteine-rich domain and a putative signal peptide sequence (GAST1 of tomato, GASA1-4 of Arabidopsis and GIP of petunia and RSI-1 of tomato) (Shi, L., et al., Plant J. 2, 153-159, 1992; Taylor, B. H., et al., Mol. Gen.
Genet. 243, 148-157, 1994; Herzog, M., et al. Plant Mol. Biol. 27, 743-752, 1995;
Ben-Nissan. G. , et al. , Plant Mol. Bio1.32, 1067-1074, 1996). GEG expression was experimentally induced by a treatment with gibberellic acid (GA3), which is similar to previous reports indicating that these genes are susceptible of being regulated by gibberellic acid or auxin. The results obtained indicate that GEG is pan of a phytohor-mone-mediated cell expansion mechanism that functions during corolla and carpel development and that mechanism can be used for developing new methods and means for providing plant raw materials with more desired and advantageous structure for agri-cultural and forestral applications.
The expression pattern of GEG correlates with completion of organ and cell elongation both in corollas and carpels. Furthermore, in transgenic plants, constitutive GEG expres-sion demonstrates that excessive GEG production is able to cause alterations in organ and cell shape during corolla and carpet development. This suggests that GEG plays a role in determining cell shape during carpet and corolla morphogenesis, thus providing function-al information for the role of GEG-like genes in plants.
In carpets, constitutive GEG expression reveals a negative interrelationship between longitudinal and radial growth. As described above, this is also evident in epidermal cells. However, in corollas, no radial expansion of epidermal cells, due to constitutive GEG expression, was observed. Furthermore, in carpets, no increase in style width was observed during endogenous GEG expression stage (Figure 4D). This would suggest that the primary role of GEG is to inhibit cell elongation. According to this hypothesis, con-stitutive GEG expression prematurely inhibits cell expansion in the longitudinal direc-tion. This could lead to growth potential of the cell to be directed passively in the radial direction as seen in the epidermal cells of the style. The alternative hypothesis that GEG
would promote radial and inhibit longitudinal expansion simultaneously is also possible.
In the present invention the dimensions of epidermal cells by scanning electron microsco-py has been measured and GEG expression was observed in the underlying parenchy-matic cells. This observation indicates that it is probable that analogous changes in cell shape can occur also in other plant cells The parallels between cell expansion and organ expansion are evident, although it is possible that in addition to cell expansion, cell divi-sion events could also contribute to the determination of the final shape at the stages analyzed.
The genes orthologous to GEG have been described earlier in various plants, e.g.
GASTI (tomato), GASAI-S (Arabidopsis), GIP (petunia), and RSI-1 (tomato) (Shi, L., et al. , Plant J. 2, 153-159, 1992; Taylor, B. H. , et al. , Mol. Gen. Genet.
243, 148-157, 1994; Herzog, M., et al. Plant Mol. Biol. 27, 743-752, 1995; Ben-Nissan, G., et al., Plant Mol. Bio1.32, 1067-1074, 1996).
The GEG-like gene/protein family shares several features that may suggest a role for GEG in regulating cell expansion. Based on our studies of GEG expression and the fact that several members (GEG, GASTI , and RSI-1 ) have been isolated based on a differential screening method, we can conclude that the mRNA is relatively abundant, characteristic of a structural role for the gene product. Furthermore, the putative signal sequence and the absence of other targeting signals suggest that the gene products are secreted, possibly to the cell wall (Shi, L. , et al. , Plant J. 2, 153-159, 1992). Another characteristic feature is regulation of gene expression with phytohormones.
The variability in the effective hormone indicates that the role of the genes may be downstream of various signal transduction pathways after their convergence.
Taken together with the data from transgenic plants suggesting that the primary role of GEG may be inhibiting axial cell expansion, it is possible that the GEG like function may be generally related to establishing cell wall properties during organogenesis in plants.
The present invention is further described in the following part in which the methodology and results are described in detail. These metl~a:,r~a as well as the results obtained should not be interpreted as restricting the scope of the protection.
Based on said description those skilled in the art can easily think of develop other equally well functioning desirable and advantageous applications for agriculture and forestry.
Example 1 Plant material Gerbera hybrida var Terra Regina used in this research was obtained from Terra Nigra BV, Holland. The control and transgenic plants were grown under identical conditions (side by side) at the same time and the age of plants was same. Developmental stages of the inflorescence are described in Helariutta, Y., et al., Plant Mol. Biol.
22, 183-193, 1993. For all analyses, samples were collected from outermost ray florets (flowers) of the inflorescence, and each transgenic and control plant sample was harvested and treated at the same time.
Example 2 Plant transformation Gerbera transformation was performed using Agrobacterium tumefaciens-mediated gene transfer as described previously (Elomaa, P., et al., Biotechnology 11, 508-511, 1993).
Transformation was verified by RNA blot analysis showing GEG expression in leaves and by DNA blot analysis. The analyses have been performed on clones of the original transgenic plants (TO).
Example 3 Isolation of plant DNA and RNA
Plant DNA was is~~lated using the methods by Dellaporta S. L., Plant Mol.
Biol. Rep.
l, 19-21, 1983. ~ :veal RNA was isolated as described in Jones, J. D. G., et al., EMBO
J. 4, 2411-2418, 1995 or by the Rneasy Plant total RNA kit (Qiagen, Chatsworth, CA).
Poly(A)+ RNA was isolated using oligo(dT) cellulose affinity chromatography (Sambrook, J., et al., Molecular Cloning: A Laboratory Manual., Cold Spring Harbor, NY: Cold Spring Harbor Laboratory, 1989).
Example 4 Construction and differential screening of a corolla cDNA library Polyadenylated RNA (5 ~,g), extracted from proximal part of ray floret corollas at devel-opmental stages from 5 to 9 (Helariutta, Y., et al., Plant Mol. Biol. 22, 183-193, 1993) was used to construct a cDNA library in the ZAPII vector (ZAP-cDNA synthesis kit;
Stratagene, La Jolla, CA). From the non amplified cDNA library, about 50.000 plaques were plated and transferred onto replica nylon membranes, and then screened differen-tially with radiolabeled first-strand cDNA pools from the ray floret tube region of the proximal part and distal part of ligule (first strand cDNA synthesis kit;
Amersham).
GEG cDNA was isolated as a clone which is expressed stronger in proximal part than distal part of the ligule. Two independent, but similar cDNA clones were isolated, sub-cloned into pUCl8 derivative, and sequenced using the AutoRead kit (Pharmacia, Uppsa-la, Sweden). The 813 by genomic fragment containing part of GEG promoter was ob-tained by applying a 5' RACE like PCR amplification on genomic DNA. The GEG
cDNA sequence and sequence of the 5' flanking region of the GEG gene have been submitted to EMBL database and the accession numbers are AJ005206 and AJ006273, re-spectively .
Example 5 RNA blot analyses and in situ hybridization Fifteen micrograms of total RNA was loaded per lane. The amount of RNA to be loaded was measured spectrophotometrically and the equal loading was confirmed by ethidium bromide staining of rRNA bands. The electrophoresis and hybridizations were made as described in Sambrook et al. , 1989. The 259-by long 3' fragment (of which 234 by is from non coding region) served as the probe. Washing conditions of 0.2 SSC (1 SSC
is 0.15 M NaCI and 0.015 M sodium citrate) and 0.1 % SDS, 58oC were applied in all RNA blots. In situ hybridization was carried out as described previously in Kotilainen M., et al., Plant Mol. Biol. 26, 971-978, 1994 using 35S-CTP-labeled antisense and sense (control) RNA probes. The probes were transcribed from the same fragment as used in the gel blot studies under the T7 promoter in vector pSP73 (SP6/T7 transcription kit; Roche Diagnostics, Mannheim Germany).
Example 6 Scanning electron microscopic analysis Corolla and carpet samples of control and transgenic plants were collected and further treated side by side at the same time. They were fixed in FAA buffer (50 %
ethanol, 5 acetic acid, and 2 % formaldehyde) overnight, and then transferred through ethanol series to 100 % ethanol, critical point dried (Balzers CPD 030 Critical Point Dryer, Bal-Tec, Liechtenstein) and coated with platinum/palladium (Agar Sputter Coater, Agar Scientific Ltd, UK). Specimens were mounted on aluminium stubs using graphite adhe-sive or tape. examined with scanning electron microscope (Zeiss Digital Scanning Micro-scope DSM 962, Karl Zeiss, Germany) in the Electron Microscopy Laboratory of the Institute of Biotechnology, University of Helsinki.
Example 7 Organ and cell measurements and statistical analysis Organ length and width measurements were done with vernier caliper in vivo, except for carpet width, which was measured from scanning electron micrographs 200 ~m below stigma. Cell length and width were measured by using scanning electron micrographs.
To study whether the differences in organ and cell expansion caused by constitutive GEG
expression are statistically significant, Student s t tests and/or Rank sum tests were per-formed. Parametric t test was used if the normality and the equal variances of samples were confirmed (P values to reject < 0.050). Non parametric Rank sum test was used if either was not confirmed. The level of confidence is P < 0.001 in all statistically signifi-cant differences mentioned in this study.
Example 8 Isolation of GEG cDNA by differential screening Both spatially restricted anthocyanin pigmentation patterns Putative signal sequence and the absence of other targeting signals suggest Another characteristic feature is regulation of gene expression with phytohormones. The variability in the effective hormone indicates that the role of the genes may be downstream of various signal transduction pathways after their convergence. (Helariutta, Y., et al., Plant Mol. Biol.
22, 183-193, 1993) and gene product accumulation patterns (Helariutta, Y. , unpublished) in various regions of the gerbera ray floret corolla indicate region-specific control of gene expression along the longitudinal axis of the corolla. We performed several differential screening schemes along this axis during the late stages of corolla morphogenesis to isolate genes with differential expression within the corolla. In this context, we isolated a cDNA as a clone whose expression is stronger in the proximal part of the corolla than in the distal part. Based on high similarity to GASTI-like genes, we have named this cDNA
GEG.
Sequence comparisons show that GEG belongs to a family of genes that are transcrip-tionally regulated by phytohormones in different plants. The predicted GEG
protein has high sequence similarity with proteins encoded by genes whose expression is induced by gibberellic acid (GASTI of tomato, GASAI-4 of Arabidopsis, and GIP of petunia) or by auxin (RSI-1 of tomato) (Shi, L. , et al. , Plant J. 2, 153-159, 1992; Taylor.
B. H. , et al. , Mol. Gen. Genet. 243, 148-157, 1994; Herzog, M., et al. Plant Mol. Biol. 27, 743-752, 1995; Ben-Nissan, G., et al., Plant Mol. Bio1.32, 1067-1074, 1996).
All of the derived polypeptides have a putative signal sequence at their N termini, with cleavage sites predicted according to von Heijne, G. , Nuclear acid research 14, 4683-4690, 1986.
Because other targeting signals have not been identified, it has been proposed that these gene products are targeted into the extracellular space or into the cell wall.
Among 60 C-terminal amino acids, there are 22 identical residues of which 12 are cysteines.
During DNA gel blot analysis, the probe (a 259-by long 3' fragment of the GEG
cDNA, 90% noncoding) recognized one or two bands at the stringency used for RNA gel blot-ting. This most probably indicates that the expression analysis results presented below correspond to transcription of a single locus, and that the two bands found in some di-gests were due to restriction length polymorphism in the heterozygous cultivar. During low stringency DNA gel blot analysis, the full-length GEG cDNA probe recognized more bands, suggesting that there is a small gene family of GEG-like genes in the ger-bera genome (data not shown).
Example 9 GEG mRNA is abundant in corollas and carpets The developmental expression pattern of GEG was studied by using RNA gel blot analy-ses. The expression of GEG is highest in floral organs, in addition a faint signal was detected in RNA from leaf blades. Strong GEG expression was observed in corolla tissue (both tube and ligule regions) and carpets, with more moderate signals in the scape (flo-ral stem) and the receptacle (terminal enlargement of floral stem) (Figure 1 ) . To under-stand the role of GEG in plant development, we focussed on GEG expression in corolla and carpet.
GEG expression was studied temporally at different stages of ray floret corolla develop-ment (Figures 2A to 2F, and Helariutta, Y., et al., Plant Mo?. l3iol. 22, 183-193, 1993.
The expression correlates temporally with opening of both individual florets and the whole inflorescence, being induced at stage 7 (Figure 2G). Because of the large size of ray floret corollas in gerbera, we were able to isolate RNA from various parts of the corolla over time and study the developmental induction pattern of GEG
expression by using RNA gel blot analysis. The pattern is intriguing. Just prior to the opening of the flower - and unfolding of the corolla - the onset of GEG expression occurs almost simultaneously from both ends of the corolla. The very first signal can be seen in the proximal part of the corolla, more precisely in the joint region of tube and ligule (Figure 2H: stage 7). During opening, the proximal expression proceeds in both directions:
basipetally into the tube and acropetally into the ligule. Almost simultaneous to the onset of proximal expression, GEG expression also starts from the distal end of the corolla.
This expression proceeds basipetally towards the middle of the ligule, where both proximal and distal expression domains meet just as the corolla has opened (Figure ZH:
stage 8). GEG expression continues at a high level until senescence takes place (data not shown). Ih situ hybridization analysis of GEG expression pattern revealed that the transcript can be detected both in the mesophyll and in the epidermis during opening of the corolla (Figure 3B).
In carpets, GEG expression was studied by gel blotting using RNA from samples taken before and after the opening of ray florets at developmental stages 6 and 8, respectively (Figures 2C to 2F and Helariutta, Y., et al., Plant Mol. Biol. 22, 183-193, 1993). As shown in Figure 2G, the onset of GEG expression coincides with the opening of the florets. In the style, GEG mRNA was detected in the outer epidermis and in parenchyma (cortex), but not in transmitting tissues (Figure 3A).
Example 10 Temporal correlatian of GEG expression with cessation of organ and cell elongation in corollas and c.;ay gels Biometric analyses (Figure 4) of corolla growth show that before its opening, the corolla expands both longitudinally and laterally. Soon after opening, growth ceases in both directions (Figures 4A and 4B). Temporally, GEG expression follows tightly the cessa-tion of corolla growth, and is detected everywhere in corolla tissues just after opening (Figure 2D to 2F, and 2H).
The temporal GEG expression pattern along the apical-basal axis of corolla made it important to analyze whether GEG expression correlates with cessation of cell elonga-tion. Cell length was measured in the distal and central regions of corolla (Figure 2H, regions 7 and 5, respectively) just after stage 7 (7+) and at stage 8. At these stages, GEG mRNA is present in the distal region, but reaches the central region just prior the stage 8 (Figure 2H).Cell length measurements revealed that cells in the distal region do not elongate, whereas in the central region, axial cell elongation takes place (Figure SA).
The cell length differences between stage 8 middle cells and other groups are statistically significant (Rank sum tests, P < 0.001). Cell width growth was detected both in distal and middle parts of corolla between stages 7 + and 8 (Figure 5 B) . Thus, GEG
expression strictly correlates with the cessation of cell expansion along the apical-basal axis.
Similar to corolla, carpet organogenesis was characterized in more detail using biometric analyses (Figure 4). Carpet length and width in the outermost ray florets were measured at various stages of inflorescence development. The opening of ray floret corollas and the whole inflorescence coincides with a change in the longitudinal expansion of carpets.
Elongation of the carpets takes place before the opening of the floret, being most rapid just prior to the opening. After opening, the elongation of carpets has ceased (Figures 2F
and 4C). In the radial direction, the styles do not expand statistically during the elonga-tion period or later (Figure 4D). Thus, in carpets the cessation of elongation is also temporally correlated with GEG expression.
Cell elongation coincides with the patterns described in organs, the epidermal cells of the style elongate before the opening of the floret but not later (Figure 4E).
Therefore, cell elongation, at least to a large degree, is responsible for the observed carpet growth de-scribed above. In both corollas and carpets, GEG expression correlates temporally with cessation of cell expansion along the apical-basal axis.
Example 11 Transgenic plants that overexpress GEG have shorter corollas Detailed temporal analysis of the developmental regulation of GEG shows that its tran-scription correlates with cessation of cell elongation both in the corolla and in the carpet.
Based on this observation, we hypothesized that the functional role of the GEG
polypep-tide is to suspend cell elongation. To test this hypothesis, we generated transgenic plants in which GEG expression was under the control of a constitutively active promoter. In these plants, constitutive GEG expression should lead to premature inhibition of cell elongation. and to shorter organs with shorter cells.
The GEG cDNA was introduced into gerbera plants under regulation of the Cauliflower mosaic virus 35S promoter via Agrobacterium tumefaciens-mediated transformation.
Four constitutively GEG-expressing lines were generated, and analyses of both the length and the width of 20 outermost ray floret corollas in four transgenic plants and control plants were conducted at developmental stage 9 when corolla growth has ceased.
All four lines constitutively expressing GEG (ml, m3 , m2, and m5) have shorter corollas when compared to the non transformed line and the two control lines transformed with GEG in an antisense orientation, resulting in no or modest decline in GEG expression (Figures 6 and 7A; antisense lines with significantly reduced GEG expression levels were not ob-tained). The differences are statistically significant (t test/Rank sum test;
P < 0.001). In contrast, the corolla width in all plants of lines constitutively expressing GEG lines re-mained unchanged when compared to control lines (Figure 7B).
Example 12 Constitutive expression of GEG decreases cell length in corollas More detailed analyses of corolla and carpet phenotypes were performed with two trans-genic lines ml and m3 together with a non transformed control line as presented below.
Constitutive expression of GEG in these transformants was verified by in situ hybridiza-tion of corolla cross-sections at developmental stage 6, when endogenous GEG
expres-sion is not yet present and by RNA gel blot analysis of leaf tissues where the endogenous expression is very low. In situ analyses show that all cell types overexpress GEG (data not shown).
In the corolla of both ml and m3 lines together with the control line, the length and the width of epidermal cells were measured at the central part of the proximal end of the ray floret corolla ligules on their adaxial sides at developmental stage 8 (Figure 8A). In plants constitutively expressing GEG, cell length was reduced in a statistically significant manner (t test; P < 0.001) but no difference in cell width could be measured (Figures 8B, 8C, 9A, and 9B). As a conclusion, the major impact of constitutive GEG
expression is the cessation of the axial cell expansion of epidermal cells in the ligule.
Example 13 Epidermal cells of the style are shorter and wider in lines constitutively expressing GEG
Compared to the control line, transgenic lines constitutively expressing GEG
has a de-crease in carpet length and an increase in carpet radius (Figures 10, 11A, and 11B). A
comparison of cell length and the width of style epidermal cells between ml and m3 lines constitutively expressing GEG, and the control line revealed a change in elongation pattern. Even before endogenous expression, at stage 6, statistically significant changes of cell length and width could be detected (t test; P < 0.001). In ml and m3 lines constitu-tively expressing GEG, cell length was reduced and the width was increased compared to control line (Figures 10, 11C, and 11D). The constitutive expression phenotypes support the view that the GEG gene product regulates cell expansion in the axial dimension during carpet development as well as during corolla development. However, in the carpet, unlike in the corolla, we observed a concomitant opposite effect in the radial dimension.
Example 14 Gibberellic acid and regulation of GEG expression in the corolla Because all of the homologous genes (see Introduction) are induced by phytohormones and because expression is spatially and temporally regulated, we studied whether GEG
expression reacts to GA3. Exogenous GA3 application upregulated GEG expression in ray floret corollas of detached inflorescences (Figure 12). A short pulse of GA3 was able to induce GEG in 2 hrs. However, because maximal levels of GEG mRNA were seen not before than 24 hrs after GA3 application, it is possible that GA
stimulation of GEG
expression is indirect or decline of gibberellic acid concentration (rather than increase) induces GEG expression.
We have also isolated the genomic 5' flanking sequence of GEG. It contains two sequence motifs that are found in the flanking regions of rice and barley -amylase genes whose expression is regulated by gibberellic acid (Huang, N. , et al. . Plant Mol. Biol.
14, 655-668, 1990; Skriver, K., et al., Proc. Natl. Acad. Sci. USA 88, 7266-7270, 1991. This further supports the idea that GEG expression is developmentally regulated by gibberellic acid.
Figure 1. RiVA gel blot hybridisation analysis showing the tissue specificity of GEG
expression.
Autoradiography of an RNA gel blot probed with a 259-by lo:ug 3' fragment of the GEG
cDNA (90 % noncoding). Fifteen micrograms of total RNA was loaded per lane and equal loading was confirmed by ethidium bromide staining. Organs covering several developmental stages were examined. Scape, floral stem; receptacle, terminal enlarge-ment of floral stem.
Figure 2. Analysis of GEG expression during corolla and carpet development.
(A) to (F) Different developmental stages of gerbera inflorescence, according to Helariut-ta et al. (1993).
(A) The developmental stage is 1, (B) 3, (C) 5, (D) 7, (E) 7.5, and (F) 8.
(G) The expression of GEG in carpet and corolla correlates with opening of both individ-ual ray florets and the whole inflorescence.
Spatial partition of ray floret corolla. Regions are indicated above the gel.
The onset of expression occurs from both ends of the corolla (stage 7, regions 2 and 7) and just as the corolla has opened. Both expression domains meet at the middle of the ligule (stage 8, region 5). Region 1 is the tubular part of ray floret corolla (tube); region from 3 (proxi-mal region) to 7 (distal region) represent the ligular part of the corolla.
GDFRI is used as a loading control. The developmental stages are the same as presented in (A) to (F).
Figure 3. Analysis of GEG expression in carpet and corolla by in situ hybridization.
In both organs (stage 7.5), GEG expression is seen in epidermal and parenchymatic cells as white silver grains. In situ analysis were carried out using the 35S-CTP-labeled an-tisense and sense (control, data not shown) RNA probes. The probes were transcribed from the same 3' fragment of GEG cDNA as used in RNA gel blot analysis.
(A) Cross-section e;' carpet style.
(B) Cross-section: c:~ marginal region of proximal part of corolla ligule.
Bar = 100 ~cm for (A) and (B).
Figure 4. Biometric analysis of corolla and carpet length and width development.
(A) and (B) Corolla length and width, respectively: Temporal GEG expression tightly follows the cessation of corolla expansion in both longitudinal and lateral directions (see also Figure 2) .
(C) Carpet length: In the carpet, cessation of elongation temporally correlates with GEG
expression.
(D) Carpet width: The carpet styles do not expand in radial direction during the elonga-tion period or later.
(E) Carpet cell length: In carpet the epidermal cells of style elongate before opening of the floret but not later, thus the retardation of cell elongation correlates with GEG expres-sion.
Timing of different developmental stages (described in Helariutta, Y. , et al.
, Plant Mol.
Biol. 22, 183-193, 1993) was measured by following the development more than inflorescences under our standard greenhouse conditions. The lengths and widths of both corolla and carpet, shown in (A) to (D), were measured from 15 to 30 outermost ray florets at each developmental stage. Samples were collected at least from two different inflorescences. Carpet cell length (E) of 72 epidermal cells of each time point was measured. Cell lengths of 18 epidermal cells 200 - 400 ~.m below the stigma of each car-pet were determined, and the average cell length of four carpets was measured.
Numbers below the curves correspond to the developmental stages of inflorescence (see Figures 2A to 2F). Error bars indicate the standard deviation.
Figure 5. Cell length and width in distal and central regions of ray floret corolla just prior and after the opening (stages 7+ and 8, respectively).
GEG is expressed in proximal part at both stages, whereas GEG expression reaches the central region just prior the stage 8 (see Figure 2H).
(A) Corolla cell length in microns. The cells in distal region do not elongate, whereas the cells in central region elongate. Thus, GEG expression strictly correlates with cessa-tion of cell expansion along the apical-basal axis. Tip, distal region; Mid, central region.
(B) Cell width (~,m) growth was detected both in distal and central regions of corolla.
Cell length and width were measured with vernier caliper using scanning electron micro-graphs. The length of forty cells in three distinct ray floret corollas each was measured at each point. At distal region of corolla the measurements were done at 1 mm from the tip. Cell widths were measured by counting cell numbers on 36 of 570 ~,m long trans-verse lines and counting the average cell widths of each line. Error bars indicate the standard deviation.
Figure 6. Comparison of the ray floret corollas of a non transformed line (wt) with that of an m3 plant constitutively expressing GEG before (stage 7), during (7.5), and after (9) the opening of ray florets.
Figure 7. Analysis of corolla length and width for four lines constitutively expressing GEG and the control lines.
(A) Corolla length (mm). Length of the outermost ray floret corollas of wild-type, consti-tutively GEG expressing lines (ml, m3, m2, and m5), and two GEG antisense lines with no (t4) or a modest (t9, 80% remaining) decline of GEG expression. All four lines con-stitutively expressing GEG have statistically shorter corollas compared to the control lines.
(B) The corolla width (mm) of all lines constitutively expressing GEG remained unchanged when compared to control lines.
Forty outermost ray floret corollas of two inflorescences of each line at stage 9 were collected. Corolla width and length of four lines constitutively expressing GEG (ml, m3, m2, and ms), a non transformed line and two antisense lines (with no or modest effect in GEG expression) were measured. Error bars indicate the standard deviations.
Figure 8. Analysis of the effects of constitutive GEG expression on corolla epidermal cells.
(A) The epidermal cells are organized into longitudinal files running along the apical-bas-al axis of corolla.
(B) Scanning electron microscopy of the adaxial (upper) side of proximal part of ray floret corolla of a non transformed control line (stage 8). The area in (B) is marked with a white box in (A). One of the epidermal cells is highlighted.
(C) Scanning electron microscopy of the corresponding region of an ml line constitutive-ly expressing GEG. Bar in (C) = 75 ,um for (B) and (C).
Figure 9. Cell lengths and widths in the same regions as described in Figure 8 of ml and m3 lines constitutively expressing GEG and a control line (wt). In plants constitutively expressing GEG, cell length was reduced but no difference in cell width could be mea-sured.
(A) Corolla cell length in microns. The cell lengths in these two lines constitutively expressing GEG are shorter when compared to control and the differences are statistical-ly significant.
(B) Corolla cell width in microns. Cell widths of these lines constitutive expressing GEG
did not differ from that of a control line.
Three ray floret corollas of transgenic lines ml and m3 together with a non transformed control line were collected (stage 8), and cell length and width were measured at the region marked with a white box in the Figure 8A. In corollas, transverse lines were drawn on micrographs, and cells were chosen at intervals of 1 cm for length measure-ments. Cell length of about 200 cells were measured of ml, m3, and a control line. Cell width was measured by counting cell numbers on 30 - 36 of 570 ~.m transverse lines and counting the average cell width of each line (approximately 40 cells per line).
Figure 10. Scanning electron microscopy of the epidermis of stylar part of the carpet 300 m below the stigma. In an ml line constitutively expressing GEG, cell length was reduced and the width was increased compared to control line.
(A) A non transformed control line and, (B) an ml line constitutively expressing GEG at stage 6. Bar = 100 ~,m for (A) and (B).
Figure 11. Analysis of the effects of constitutive GEG expression on epidermal cells of the carpet style.
(A) Carpet length in millimeters. Carpet length of lines constitutively expressing GEG is shorter when compared to a control line.
(B) Carpet width in microns. Compared to a control line, carpet radius has increased in lines constitutively expressing GEG.
(C) Carpet cell length in microns. Comparison of cell length of ml and m3 to a non transformed control line reveals that epidermal cells of style of lines constitutive express-ing GEG are shorter when compared to a control line.
(D) Carpet cell width in microns. The epidermal cells of constitutively GEG
expressing lines are wider when compared to a control line.
Twelve to twenty carpets of two lines constitutively expressing GEG (ml and m3) and a non transformed control line were measured. Carpet length was measured at developmen-tal stage 9; carpet width, epidermal cell length, and width were measured at stage 6. Cell length of 18 individual epidermal cells 200 - 400 ~,m below the stigma of each carpet and the average cell length of 12 - 20 carpets of each line were measured. The differences presented in (A), (B), (C) and (E) are statistically significant. Error bars indicate the standard deviations.
Figure 12. Exogenous gibberellic acid application upregulates GEG expression in ray floret corollas RNA gel blot showing GEG expression after the addition of GA3 just before the opening of the inflorescence (stage 7+). The scape (floral stem) was cut 5 cm below inflores-cence.
(A) The control inflorescences were grown on 50 mM sucrose.
(B) Induction of GEG expression was detected when inflorescences were grown on mM sucrose with 5 ~,M GA3.
(C) Induction of GEG expression was also detected when infl~>-:e.~~;;:ences were first incu-bated in 50 mM sucrose with 50 ~,M GA3 for 5 min, and then transferred to 50 mM
sucrose medium.
Approximately 10 ray floret corollas were collected for RNA isolation at each time point (hours) after GA3 addition.
SEQUENCE LISTING
(1) GENERAL INFORMATION:
(i) APPLICANT:
(A) NAME: TEERI, Teemu, et al.
(B) STREET: Biotekniikan instituutti, Viikinkaari 9 (C) CITY: Helsinki, Helsingin yliopisto (D) STATE: Viikin biokeskus (E) COUNTRY: FINLAND
(F) POSTAL CODE (ZIP): FIN-00014 (G) TELEPHONE: 358-9-70859423 (H) TELEFAX: 358-9-70859570 (ii) TITLE OF INVENTION: METHODS AND GENE PRODUCTS FOR PZTERING
THE SHAPE OF CELLS AND ORGPNS IN PLANTS
(iii) NUMBER OF SEQUENCES: 5 (iv) COMPUTER REP.DABLE FORM:
(A) MEDIUM TYPE: Floppy disk (B) COMPUTER: IBM PC compatible (C) OPERATING SYSTEM: PC-DOS/MS-DOS
(D) SOFTWARE: PatentIn Release #1.0, Version #1.30 (EPO) (2) INFORMATION FOR SEQ ID NO: l:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 60 amino acids (B) TYPE: amino acid (C) STRANDEDNESS:
(D) TOPOLOGY: linear (ii) MOLECULE TYPE: protein (v) FRAGMENT TYPE: C-terminal (vi) ORiGIN.~L SOURCE:
(A) ORGANISM: Gerbera hybrida (xi) SEQUENCE DESCRIPTION: SEQ ID N0: 1:
Asn Cys Gly Ala Ala Cys Lys Ala Arg Cys Arg Leu Ser Ser Rrg Pro Asn Leu Cys His Arg Ala Cys G1y Thr Cys Cys Ala Arg Cys Arg Cys Val Pro Pro Giy Thr Ser Gly Asn Gln Lys Va1 Cys Fro Cys Tyr Tyr Asn Met Thr Thr His Gly Gly Arg Arg Lys Cys Pro (2) INFORMATION FOR SEQ ID N0: 2:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 101 amino acids (B) TYPE: amino acid (C) STRANDEDNESS:
(D) TOPOLOGY: linear (ii) MOLECULE TYPE: protein (xi)SEQUENCE DESCRIPTION: NO: 2:
SEQ ID
Met A1a Ile Ser Lys Pro Phe Ala Phe Ala Leu Leu Ser Met Leu Leu Leu Leu Leu G1n Leu Gly Gln Tyr Glu Met Val Asn Lys Ile Ala Asp Glu Ala Thr Ile Ala Ala Ser Lys Ile Asn Cys G1y Ala A1a Cys Lys AlaArg Cys Arg Ser Arg Pro Asr_ Leu Cys His A1a Leu Ser Arg Cys GlyThr Cys Cys Arg Arg Cys Va1 Pro Pro Gly ,Ser Ala Cys Thr Gly AsnGln Lys Val Pro Tyr Tyr Asn Met Thr Thr G1y Cys Cys His Gly Arg Arg Lys Cys Pro (2) INFORMATION FOR SEQ ID NO: 3:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 552 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: cDNA
(xi) SEQUENCE DESCRIPTION: SEQ ID N0: 3:
CTTCTTCTTC TCCAACTTGG TCPAGCTTAT GAA_ATGGTGA ACAAGATTGA TGAGGCGACC 120 ATCGCTGCTT CCP.APATCAR TTGTGGAGCA GCATGTAAGG CCAGGTGCCG GTTATCGTCG 180 AGGCCAP_ACT TGTGCCACAG GGCATGTGGG ACCTGTTGTG CCCGTTGCAG ATGCGTGCCA 2S0 TTACACP.ATA AAAAGTTGTG AARTAAATTG AATTTTATGC TTGTTAAAAG TTTP_AA.P.AAA 540 AAAAAAP~AA.A AA 5 5 2 (2) INFORMATION FOR SEQ ID N0: 4:
( i ) SEQUENCE CHAR.A.CTERISTICS
(A) LENGTH: 832 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: double (D) TOPOLOGY: linear (ii) MOLECULE TYPE: other nucleic acid (A) DESCRIPTION: /desc = "promoter"
(xi) SEQUENCE DESCRIPTION: SEQ ID N0: 4:
AATCAATCTT TGTAGGGAGC~AATTTAGGAT AGTTTAGTTC AGTATATGTC AATATATCTG 60 ATCGTTTGAG AAAA.~AAGGA TA_ATAAAGAC GATAATATTC TTTATTTTCC GACCTAAAGA 120 GTTAGGTAAG TTATAATTTA CTTTF.ATCGC TCGGTGTTTA ATGAAATATT ATATCCAAGT 180 CTCGACTCTC AATAAGTGTT AACATCTTTT TAGGTCGTAT TTGCTTACCA AAA.A.ACCTA.A 240 TTACAATATC ATGGTTATCA AP.AAATA.'~TA TCTTCTCTTG TTATTCTTTC GTGAAAACTA 360 CCGTTCCACT GTTACATACT GGATAGTACA TTTTATCAAC CATTCCGCTG TCACAA.A.A.AA 480 p~ZlA ATTAATACCG TCTTTTTAA.~ AGTCGATP.PA AAGGATAACA AGGATAACAA 540 CCGTTTP.ATC ATCAAATTAT TTGCAGTT.zIA GAGGTCATGA GAGATATCAT CCTAGCTAAA 600 TGCTTTTAGG TGAAACTCTT GTGGTGTCAA TAACATTTAA ATTTATAAAG AAP..AAGAGAA 660 ATTATTAAAA TCTTP.AATTG TTTTTTTCAA AAAGAGAAAT TATTAAAATC TTAAATTGTT 720 TTTTTCTTCT TATP.ATTATT ATTGACTCTC TTTCTTTGTC TATAP.ATAGG ATGC_~AGTCT 780 CCAACCTTAG GCACAPACTC AACCCAAPAC AAAG.~AAGTG TAGTCATAAG CC 832 (2) INFORMATION FOR SEQ ID NO: 5:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 180 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (A) DESCRIPTION: /desc = "3' end of the cDNA"
(xi) SEQUENCE DESCRIPTION: SEQ ID N0: 5:
AATTGTGGAG CAGCATGTAA GGCCAGGTGC CGGTTATCGT CGAGGCCAAA CTTGTGCCAC 60 , AGGGCATGTG GGACCTGTTG TGCCCGTTGC AGAT'GCGTGC CACCGGGTAC TTCCGGTAAC 120 CAAA.AGGTTT GCCCTTGCTA CTACAACATG ACCACCCATG GTGGCAGAAG AAAGTGCCCT 180
Claims (7)
1. Isolated and essentially purified nucleic acid sequences for altering the size and shape of plant cells or plant organs characterized in, that the GEG-like nucleic acid sequences encode GEG-like gene products having a C-terminal domain (SEQ ID
NO:1:), which is substantially homologous to the C-terminal part of gene product of GEG (SEQ
ID NO:2:).
NO:1:), which is substantially homologous to the C-terminal part of gene product of GEG (SEQ
ID NO:2:).
2. The nucleic acid sequence according to claim 1, characterized in, that the GEG-like nucleic acid sequences are capable of hybridizing with SEQ ID NO:3:
(GEG
cDNA) obtainable from Gerbera hybrida under defined conditions.
(GEG
cDNA) obtainable from Gerbera hybrida under defined conditions.
3. A nucleic acid sequence characterized in, that it comprises the GEG-promoter sequence (SEQ ID NO:4:).
4. The GEG-like gene products expressed by the nucleic acid sequence according to claims 1-3 for altering the size and shape of plant cells or plant organs, characterized in, that the GEG-like gene product is a polypeptide having C-termi-nal domain substantially homologous with SEQ ID NO:1:, comprising one or more able cysteine residues said GEG-like gene product having the capacity of spatiotemporal control of cell growth.
5. The GEG-like gene product according to claim 4, characterized in, that the C-terminal domain comprises at least 4, preferably at least 8, most preferably at least 12 cystein residues.
6. The GEG-like gene product according to claim 5, characterized in, that it encodes a GEG-like gene product with a C-terminal domain comprising 12 cystein residues.
7. The GEG-like gene product according to claims 4-6, characterized in, that it comprises a polypeptide having an amino acid sequence substantially homologous with SEQ ID NO:1:, excluding the amino acid sequence SEQ ID NO:2:.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FI991201 | 1999-05-27 | ||
FI991201A FI991201A0 (en) | 1999-05-27 | 1999-05-27 | Method and gene products for changing the shape of cells and organs in plants |
PCT/FI2000/000475 WO2000073461A1 (en) | 1999-05-27 | 2000-05-26 | Methods and gene products for altering the shape of cells and organs in plants |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2371597A1 true CA2371597A1 (en) | 2000-12-07 |
Family
ID=8554743
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002371597A Abandoned CA2371597A1 (en) | 1999-05-27 | 2000-05-26 | Methods and gene products for altering the shape of cells and organs in plants |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP1181370A1 (en) |
JP (1) | JP2003501036A (en) |
AU (1) | AU4760900A (en) |
CA (1) | CA2371597A1 (en) |
FI (1) | FI991201A0 (en) |
WO (1) | WO2000073461A1 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BR0313110A (en) | 2002-08-02 | 2005-07-12 | Basf Plant Science Gmbh | nucleic acids encoding regulatory proteins of sugar and lipid metabolism in plants and their uses |
-
1999
- 1999-05-27 FI FI991201A patent/FI991201A0/en unknown
-
2000
- 2000-05-26 AU AU47609/00A patent/AU4760900A/en not_active Abandoned
- 2000-05-26 JP JP2001500773A patent/JP2003501036A/en active Pending
- 2000-05-26 WO PCT/FI2000/000475 patent/WO2000073461A1/en not_active Application Discontinuation
- 2000-05-26 EP EP00929586A patent/EP1181370A1/en not_active Withdrawn
- 2000-05-26 CA CA002371597A patent/CA2371597A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
AU4760900A (en) | 2000-12-18 |
JP2003501036A (en) | 2003-01-14 |
EP1181370A1 (en) | 2002-02-27 |
WO2000073461A1 (en) | 2000-12-07 |
FI991201A0 (en) | 1999-05-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Kotilainen et al. | GEG participates in the regulation of cell and organ shape during corolla and carpel development in Gerbera hybrida | |
Dudareva et al. | Evolution of floral scent in Clarkia: novel patterns of S-linalool synthase gene expression in the C. breweri flower. | |
KR100861330B1 (en) | Dna encoding a plant deoxyhypusine synthase, a plant eukaryotic initiation factor 5a, transgenic plants and a method for controlling senescence and programmed cell death in plants | |
Burke et al. | Characterization of a polyubiquitin gene from Arabidopsis thaliana | |
Ben-Nissan et al. | The petunia homologue of tomato gast1: transcript accumulation coincides with gibberellin-induced corolla cell elongation | |
JP2003174891A (en) | Plant-derived enzyme and dna sequence and use thereof | |
US7482509B2 (en) | Transgenic plants carrying neoxanthin cleavage enzyme gene | |
EP0889963A1 (en) | Nucleic acid molecules encoding cytochrome p450-type proteins involved in the brassinosteroid synthesis in plants | |
Arsenijevic-Maksimovic et al. | Rhizobia modulate root-hair-specific expression of extensin genes | |
AU711118B2 (en) | Fruit ripening | |
US7232941B2 (en) | Cellulose synthase promoter and method for modifying cellulose and lignin biosynthesis in plants | |
AU781500B2 (en) | Method for enhancing cellulose and modifying lignin biosynthesis in plants | |
US20040123344A1 (en) | Novel gene encoding an f-box protein which regulates leaf longevity in arabidopsis thaliana and mutant gene thereof | |
CA2371597A1 (en) | Methods and gene products for altering the shape of cells and organs in plants | |
CA2325819C (en) | Seed-coat promoters, genes and gene products | |
HUT73216A (en) | Dna constructs coding for protein ga1 of arabidopsis thaliana, vectors containing the dna constructs, host cells transformed with the vectors, transgenic plants containing the dna constructs, propagation materials thereof; purified protein ga1 ... | |
WO1993021322A9 (en) | A method for controlling and determining plant organ morphogenesis, a homeotic gene, a promoter element therefor, and related uses thereof | |
EP0640132A1 (en) | A method for controlling and determining plant organ morphogenesis, a homeotic gene, a promoter element therefor, and related uses thereof | |
US7396978B2 (en) | Seed coat gene and gene product | |
US20040016023A1 (en) | Modification of plant cell wall component and method of regulating development differentiation | |
CA2315900A1 (en) | Apple mads-box protein, gene encoding said protein, antibody against said protein, method for detecting transcript of said gene or protein expressed therefrom and process for preparing transgenic plant containing said gene | |
JP2003180372A (en) | Gene participating in plant cell wall synthesis and cell form formation and its utilization | |
WO1998059056A1 (en) | Pathogen-resistant monocot plants and method | |
Dudareva et al. | C. breweri Flower |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
FZDE | Dead |